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Bacteriocin produced by lactic acid bacteria (LAB) are able to inhibit the growth of Listeria 
monocytogenes, and because of their GRAS (generally recognized as safe) status, they have 
become subjects of interest for use as additives in foods as an antimicrobial. 
Bacteriocins work by different modes of action (MOA). By screening bacteriocins based on mode 
of action against Listeria monocytogenes, a multiple MOA bacteriocin cocktail can be created for 
use as a “hurdle” technology to inhibit the growth of Listeria, as well as prevent the outgrowth of 
spontaneously-resistant listerial strains. 
We developed a series of Listeria strains resistant to three different MOA and screened animal-
sourced samples for bacteriocins displaying a unique fourth MOA. From this procedure, two unique 
bacteriocin-producing bacteria were isolated and identified using 16s PCR. Cell-free supernatant 
(CFS) containing bacteriocin from one of these isolates, Streptococcus spp. 323 was purified using 
ammonium sulfate precipitation, C18 sep-pack elution, and elution from reverse-phase HPLC with 
an acetonitrile gradient. Purified sample was submitted to the Oklahoma State University Core 
Facility for analysis by mass spectrometry. 
Certain bacteriocin-producing cultures have been implicated as opportunistic pathogens and thus 
merits analysis of these strains for virulence factors prior to application of CFS in foods. 
Streptococcal and enterococcal strains were analyzed for hemolysin and gelatinase production, with 
only one strain producing hemolysin and four displaying gelatinase production. Results assisted in 
the development of a bacteriocin cocktail utilizing 3 MOA for use in hotdog applications. 
Frankfurters were formulated with different antimicrobial treatments (bacteriocin cocktail 
applications, NovaGard, Durafresh 2016) and underwent a series of shelf-life studies. Studies 
showed antimicrobials tested had a significant decrease in L. monocytogenes from control hotdog 
batches. Most notably, the use of bacteriocin cocktails within the meat matrix provided a nearly 7-
log reduction 16 weeks after inoculation with L. monocytogenes.  
Given the results of this study, the use of multiple MOA bacteriocin cocktails significantly reduce 
L. monocytogenes in hotdogs and can be used as an effective antimicrobial intervention in foods.   
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REVIEW OF LITERATURE 
 
INTRODUCTION 
Foodborne illness due to pathogens such as Salmonella spp., E. coli, and Listeria monocytogenes, 
affects an estimated 48 million individuals each year in the United States (Centers for Disease 
Control and Prevention, 2016). Recent outbreaks of listeriosis, caused by Listeria monocytogenes, 
signal the urgency with which better antimicrobial solutions must be found within the food 
industry. An ideal solution would be an effective, natural product, solving both safety concerns 
and manufacturers’ desires for clean labels. 
Listeriosis contributes an estimated 260 deaths to the annual 3000 deaths resulting from 
foodborne illness. While this is a small proportion of the annual number of foodborne illnesses in 
the United States, the severity of this illness contributes to its high mortality rate (Centers for 
Disease Control and Prevention, 2017). Consumption of certain foods, including deli meats, 
cheeses, and frankfurters, have a high risk of the disease associated with them (Center for Food 
Safety & Applied Nutrition et al., 2003), and thus merit concern within the food industry.  
Accompanying these safety concerns, today’s consumer is increasingly conscious of their health 
and the products they consume. Because of this, recent trends aim toward the production of 
minimally processed foods without the use of chemical preservatives (Cleveland et al., 2001).
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Use of bacteriocins, short antimicrobial peptides produced by lactic acid bacteria (LAB), could 
solve this issue, as LAB have been safely consumed for millennia in a wide variety of fermented 
products. The diversity of foods in which LAB bacteriocins can be found also contributes to 
interest in use of these products, as they are able to tolerate diverse conditions. 
Previous studies have looked at the potential role of bacteriocins from LAB as antimicrobial 
measures in ready-to-eat (RTE) foods (Budde et al., 2003; Chen et al., 2004; Mataragas et al., 
2003; Vijayakumar & Muriana, 2017). Additions of such products could help inhibit L. 
monocytogenes growth when used as a “hurdle” technology (Muriana, 1996). Such “hurdles” for 
Listeria could include pairing of bacteriocins with other antimicrobials to work synergistically, 
or, as proposed in this paper as well as Vijayakumar and Muriana (2017) , the use of bacteriocin 
cocktails working by multiple modes of action (MOA) to prevent resistant Listeria from 
overcoming the antagonistic action of a single bacteriocin. Use of this bacterially-derived solution 
would present a safe, natural intervention for use in industry. 
Listeria monocytogenes Virulence   
Listeria monocytogenes is a gram-positive pathogen responsible for approximately 1600 illnesses 
and 260 deaths each year (Centers for Disease Control and Prevention, 2017). Individuals 
susceptible to contracting listeriosis include children, the elderly, pregnant women, and other 
immunocompromised individuals. One specific concern is the ability of Listeria to cross the 
blood/brain barrier, as well as the placenta during pregnancy, which causes miscarriages.  
While other strains of Listeria spp. are not considered virulent to humans, Listeria 
monocytogenes contains several virulence factors that contribute to its ability to cause disease. 
Interalins A and B are surface proteins that mediate entry into the host cell (de Souza Santos & 
Orth, 2015), while listeriolysin O (LLO) is also a virulence factor implicated in Listeria’s ability 
to cause infections, allowing the pathogen to enter the cytosol of the host cell (Jordan et al., 
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2015). Listeria spreads intracellularly by the use of the virulence factor internalin C and is also 
able to manipulate actin structures within the cell to assist in movement, effectively avoiding the 
immune system (de Souza Santos & Orth, 2015). The virulence of this pathogen has led to 
Listeria monocytogenes outbreaks and has caused serious concern in the food industry, as 
contaminated food is the primary cause of listeriosis (Jordan et al., 2015).  
Role of Listeria monocytogenes within the Food Industry 
Foodborne illness is a serious issue in the United States, as an estimated 128,000 hospitalization 
cases occur annually with 3000 resulting in death (Centers for Disease Control and Prevention, 
2016). One important sector of these illnesses includes those caused by Listeria monocytogenes. 
Several factors contribute to the persistence of Listeria in the food industry. Not only is it a 
ubiquitous organism in the nature, but it also is salt tolerant, psychrotrophic, and establishes 
residence easily in food manufacturing facilities due to its ability to form biofilms (Kouakou et 
al., 2010; Luber et al., 2011), allowing for successful evasion of common food preservation and 
food safety practices. Biofilm formation, in particular, allows for the persistence of the pathogen 
in food production environments as it contributes to the ability of Listeria to tolerate industrial 
sanitizers by providing a protective layer. Niches of biofilms are established in areas where 
equipment is difficult to clean and reach, as well as within grooves and scratches in worn 
equipment (Jordan et al., 2015). 
With outbreaks in products such as Blue Bell ice cream and cantaloupes (Center for Disease 
Control and Prevention, 2018a), it is apparent that steps taken to prevent contamination in 
industry are not always effective. Listeria is particularly problematic in the ready-to-eat (RTE) 
sector of the food industry, where cooking products is not required prior to ingestion by the 
consumer. Because of the dangers of listeriosis, RTE foods have been labeled as “high risk” 
(Center for Food Safety & Applied Nutrition et al., 2003; Rocourt et al., 2003). In an evaluation 
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of 20 different brands of hotdogs, one of the major at-risk foods, Wang and Muriana (1994) 
identified L. monocytogenes in 6 of the brands tested, a 30% incidence rate. A similar study by 
Ahmed et al. (2015) was recently conducted well after the implementation of HACCP in the food 
industry found an incidence rate of 2.07% in the 1883 RTE meat samples tested. While the 
frequency of Listeria illnesses has decreased since 2002 (Painter, 2013), outbreaks of this 
pathogen result in a higher percentage of hospitalizations than pathogens such as Salmonella and 
Clostridium perfringens (Centers for Disease Control and Prevention, 2016). This severity of 
listeriosis contributed to the decision to implement “zero tolerance” for this pathogen in foods in 
the United States (Gombas et al., 2003). 
The “zero tolerance” policy has given rise to regulations by the United States Department of 
Agriculture’s Food Safety and Inspection Service (Food Safety and Inspection Service, 2003). 
These indicate three different alternatives for implementation in RTE foods regarding the control 
of L. monocytogenes. Alternative I requires the use of a post-processing treatment as well as an 
antimicrobial, Alternative II involves the use of either a post-processing treatment or application 
of an antimicrobial, and Alternative III utilizes no additional post-processing measures, but relies 
only on GMPs (Good Manufacturing Practices), plant sanitation, and HACCP plans for sufficient 
food safety. Processors employing Alternative III as a strategy, of course, are subject to a greater 
amount of review by regulatory agencies, due to the higher risk involved (Zhu et al., 2005). 
Because hotdogs are considered high risk foods for contamination with L. monocytogenes, 
additions of lactate and diacetate have been allowed as one of many antimicrobial interventions in 
frankfurters to prevent growth of the pathogen (Maks et al., 2010); however, consumers’ demand 
for clean labels in recent years has challenged the food industry to find effective natural solutions 
to combat Listeria. One proposed solution is the use of bacteriocins, which are short antimicrobial 
peptides produced by a variety of bacteria. Bacteriocins from lactic acid bacteria (LAB), which 
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are naturally found in a wide variety of foods, have antagonistic activity against L. 
monocytogenes, which has led to a wide variety of studies performed in this area. 
Lactic Acid Bacteria (LAB) 
The LAB are a group of Gram-positive, microaerophilic bacteria that produce lactic acid by the 
fermentation of hexose sugars and do not produce catalase (Coolbear et al., 2011; Lawrence 
Berkeley National Laboratory et al., 2006). Along with lactic acid, these bacteria produce many 
other compounds, including hydrogen peroxide, organic acids, and bacteriocins (O’Sullivan et al., 
2002).  Several different genera of bacteria fall into the definition of LAB as traditionally used in 
fermentations and with food products include Carnobacterium, Lactobacillus, Lactococcus, 
Leuconostoc, Pediococcus, and Streptococcus spp. (Nettles & Barefoot, 1993), but nearly 20 
different genera have also been defined as LAB (Coolbear et al., 2011). Strains of LAB have been 
consumed safely for thousands of years, as they are used in a variety of different foods, such as 
cheeses, fermented sausages, and sauerkraut. These microbes are also credited with giving 
specific sensory characteristics unique to certain products (Coolbear et al., 2011) in addition to 
the protective action against certain pathogens (McAuliffe et al., 2001).Because of their history of 
safe use and consumption, they have been granted GRAS (generally recognized as safe) status by 
the FDA, allowing their use as food additives (Coolbear et al., 2011; Perez et al., 2014).  
LAB Bacteriocins 
Bacteriocins are short, ribosomally synthesized peptides, which show inhibitory effects, either 
bactericidal or bacteriostatic, towards other closely-related bacteria, including bacteria such as L. 
monocytogenes, Staphylococcus aureus, and Clostridium spp. (Klaenhammer, 1993; Nettles & 
Barefoot, 1993). Some bacteriocins, including nisin and other class I bacteriocins, are subject to 
post-translational modifications (Jack & Sahl, 1995; McAuliffe et al., 2001). Strains of LAB 
bacteria can encode multiple bacteriocins in their genes, though all bacteriocins may not be 
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expressed at once (Henning, 2016; Nes et al., 2007). In fact, production of one bacteriocin can 
hinder the production of others by the same bacterium (Perez et al., 2012). Bacteriocins work by 
several different modes of action (MOA), which include the inhibition of peptidoglycan, pore 
formation, or affecting the target organism’s DNA or RNA (Cleveland et al., 2001).  
These naturally-produced peptides are promising for the food industry due to their heat and pH 
stability, as well as their safe ingestion by humans. Bacteriocins can have a wide or narrow 
spectrum of activity, meaning a single bacteriocin could have antagonistic effects on multiple 
genera, or could display activity against very few bacteria. This difference in the amount of 
activity could be beneficial and applicable to the food industry. Wide spectrum bacteriocins could 
be utilized as an antimicrobial measure in foods that have high risk associated with multiple 
pathogens, such as vacuum-packaged RTE foods, where C. botulinum and L. monocytogenes 
would be pathogens of concern. On the other hand, bacteriocins with a narrow spectrum could 
also be beneficial for industry, as issues with compatibility of bacteriocins with other starter 
cultures would be more easily avoided with narrow spectra of activity. 
Classes of Bacteriocins 
Bacteriocins are typically categorized into 4 separate classes (Klaenhammer, 1988). Class I 
bacteriocins consist of lantibiotics, which are composed of the unique amino acid lanthionine, and 
include nisin (McAuliffe et al., 2001). Class II bacteriocins, which are small heat-stable peptides, 
are composed of three subgroups. Class IIa bacteriocins are characterized by their anti-Listerial 
activity, class IIb include bacteriocins requiring two peptide components for antagonistic activity, 
and class IIc bacteriocins require an additional thiol component for activity. Bacteriocins 
displaying anti-Listerial effects commonly include those found in classes I and II. Class III 
bacteriocins are large (>30kDa), heat labile bacteriocins, and finally class IV bacteriocins require 
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additional non-proteinaceous components for antagonistic activity, such as carbohydrates or 
lipids (Klaenhammer, 1988; Vijayakumar, 2014) . 
Both class I and class II bacteriocins display antagonistic activity towards L. monocytogenes, 
leading to their interest for use in the food industry. Class I bacteriocins include lantibiotics, such 
as nisin and cytolysin, an enterocin. Nisin is currently the only bacteriocin approved by the World 
Health Organization (WHO) for use in foods (Jones et al., 2005), though the bacteriocins can be 
readily isolated in foods containing LAB. 
History and Use of Nisin within the Food Industry 
Nisin is a class I bacteriocin produced by Lactococcus lactis (Guinane et al., 2005) and is 
particularly unique due to post-translational alterations, leading to the presence of a lanthionine 
amino acid (Jack & Sahl, 1995; McAuliffe et al., 2001). Nisin was first isolated in 1928 upon 
observations of inhibitory effects of certain LAB against others (McAuliffe et al., 2001). Since 
then, eight different nisin types have been identified, including Nisin A, F, Z, H, Q, U, U2, and P  
(Kaskonien et al., 2017; O'Connor et al., 2015). The lantibiotic is used in over 40 countries since 
being granted approval by the World Health Organization (WHO) (Bouttefroy & Millière, 2000), 
and given GRAS status by the USDA in 1988 (USDA, 1988; (Cleveland et al., 2001). The use of 
nisin as a direct food additive is allowed in food products within the United States as well, due to 
its historical safe use before the implementation of the 1959 Food Additives Amendment. 
Compounds without a history of safe use require intensive testing before they can be approved 
and incorporated as food additives, as mentioned in 21 CFR § 170.30 (2018). 
Nisin has been used in food systems for multiple benefits. It has been shown to inhibit 
germination of Clostridium spores in foods, as well as inhibit growth of L. monocytogenes 
(Cleveland et al., 2001; Davies & Adams, 1994; Gravesen et al., 2002; McAuliffe et al., 2001). 
Nisin is sold as a commercial antimicrobial under the name Nisaplin® (Muriana & Kanach, 
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1995) and is used by companies including Sysco and Kraft Foods (Jones et al., 2005). Nisin is 
also used in other antimicrobial mixtures, such as NovaGard®, marketed by Danisco. 
Nisin operates by the disruption of the proton motor force (PMF) in L. monocytogenes, causing 
the potassium ions to surge out of the cell (Abee et al., 1995). This disruption can be overcome. 
Resistant strains of nisin can result from gradual increases in exposure of a strain to nisin (Ming 
Xintian & Daeschel, 1993) or by mutations in the fatty acids within the target cell’s membrane, 
leading to decreased pore formation by the bacteriocin (Schillinger et al., 1998).  
Successful inhibition of L. monocytogenes (Aasen et al., 2003; Davies et al., 1997) and C. 
botulinum spores (Okereke & Montville, 1991) by nisin has been well documented in a number of 
studies. However, it has been suggested that better inhibitory activity may be seen when 
combining nisin with other antimicrobial measures or by pairing it with class II bacteriocins 
(Schillinger et al., 1998; Wan Norhana et al., 2012). One important factor that must be considered 
when utilizing nisin in fermented products is the utilization of nisin-resistant starter cultures when 
additional cultures are used (Davies et al., 1997; Harris et al., 1992). Without accounting for the 
compatibility of cultures with nisin in the product manufactured, the fermentation process could 
fail due to the inhibition of the other cultures by nisin. 
Class IIa Bacteriocins 
Class IIa bacteriocins are of particular interest in the food industry due to the subclass’s noted 
ability to inhibit Listeria. These are readily found in LAB and display a variety of activity ranges. 
Bacteriocins of this subclass typically contain between 37 and 48 amino acid residues, contain a 
high proportion of glycine residues, and contain a disulfide bridge (Ennahar et al., 2000b). Other 
common characteristics of class IIa include a conserved sequence YGNGV, present near the N-
terminal end, as well as high amounts of variation towards the C-terminus (Ennahar et al., 2000b; 
McAuliffe et al., 2001).  
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Class IIa bacteriocins target a variety of related organisms (Ennahar et al., 1999; Vijayakumar, 
2014). The amphiphilic nature of these molecules allows them to bind electrostatically to a cell’s 
wall, and then operate by forming a pore in a target cell’s membrane, disrupting the balance of 
ions and allowing contents within the cell to escape (Ennahar et al., 2000b). Interestingly, class 
IIa bacteriocin-producing strains also encode protective genes, called immunity genes, that may 
also give them partial immunity to other class IIa bacteriocins, but not all other class IIa 
bacteriocins (Ennahar et al., 2000b). Target cell death is ultimately caused by the disruption of the 
proton motile force, causing a severe depletion of ATP and ceasing active transport (Ennahar et 
al., 2000b). Furthermore, studies on genes of these LAB have indicated immunity genes show 
very little similarity from one bacteria to another, while the genes for the bacteriocins themselves 
are very closely related. It is because of the dissimilarity of the immunity genes that it is believed 
they only share the same receptors to demonstrate the same effect (Ennahar et al., 2000b). At 
least 14 class II bacteriocins exist and have been characterized, while pediocin PA-1, produced by 
Pediococcus acidilactici, is the most extensively characterized class II bacteriocin (Ennahar et al., 
1999). 
Pediocin PA-1 
Pediocin PA-1 has been examined in many studies regarding its effectiveness as a bacteriocin 
(Chen et al., 1997; Díez et al., 2012; Nieto-Lozano et al., 2010) and in several foodstuffs using a 
strain of Pediococcus acidilactici marketed as ALTA™2341 by Quest International (Chen et al., 
2004; Rodríguez et al., 2002). Studies with PA-1 have mostly shown reductions of L. 
monocytogenes in foodstuffs between 1 and 3 logs (Rodríguez et al., 2002). While reduction may 
be statistically significant, the level of inhibition and regrowth of Listeria in studies also suggests 
application of this product in food may benefit from combination with other components to obtain 
synergistic action between multiple antimicrobial measures (Pucci et al, 1988).  
10 
 
Use of Enterococcus spp. Bacteriocins 
While bacteriocins have many benefits, the production of certain other damaging compounds by 
certain strains of LAB and their role as opportunistic pathogens has been a source of concern. 
Specifically, Enterococcus spp. and Streptococcus spp. have been implicated in nosocomial 
infections, endocarditis, and foodborne illness. This can be attributed to antibiotic resistance 
development by certain strains, as well as the production of aggregation substance, gelatinase, 
hyaluronidase, and hemolysin, among other deleterious compounds (Jett et al., 1994). However, 
strains of these species, particularly Enterococcus spp., can also contribute for development of 
flavor and ripening in some cheeses without harmful effects (Franz et al., 1999).  
Enterococci produce some potent bacteriocins called enterocins (Franz et al., 2007). They are 
commonly found in animal and human digestive tracts and typically cause no harm, but certain 
virulent strains have been implicated in nosocomial infections, as they are opportunistic 
pathogens due to certain virulence factors. Even though enterococci can be opportunistic 
pathogens, these are isolated to only certain strains of E. faecalis and faecium (Jett et al., 1994),  
while many strains do not show virulence and are safely used in food products around the world. 
Members of Enterococcus spp. are credited for giving certain artisanal cheeses their characteristic 
flavors because of their ability to produce certain compounds, such as acetaldehyde (Franz et al., 
1999). They have also been used as probiotics (Klein, 2003) and have been utilized to reestablish 
balance to intestines after microbiota disruption by diarrheal diseases (Franz et al., 2011). In order 
to circumvent issues with infectious strains, screening of strains for compounds related to 
pathogenicity has been performed and some studies have looked at the use of cell-free 
supernatant against Listeria (Barman et al., 2014; Hartmann et al., 2011). Enterococci have also 
been implicated in the spoilage of meat (Franz et al., 1999), so use of its bacteriocins as a cell-
free supernatant (CFS) would address this issue, as well as the concern over certain strains’ 
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virulence. By ensuring the absence of virulence factors from CFS, the benefits of Enterococcus 
spp. could be employed for the improvement of food safety. 
Bacteriocin Production 
Bacteriocin production depends on a variety of factors, which include carbon sources, nitrogen, 
pH, and incubation temperature. Media choice is vital for production of a significant amount of 
bacteriocin. Typically, LAB cultures are grown in MRS (De Man, Rogosa, and Sharpe) medium, 
but several studies have utilized M17 medium successfully (Cheigh et al., 2002; Espeche et al., 
2014; Hartmann et al., 2011). MRS medium includes Tween 80, which is used as a source of fatty 
acids and has been found to increase bacteriocin production (Espeche et al., 2014; Todorov & 
Dicks, 2009). 
Several studies have made adjustments to these broths to determine characteristics vital for 
optimum bacteriocin production. Parente and Ricciardi (1999) found both class I and some class 
IIa bacteriocins were produced in larger amounts when glucose was used as the carbon source; 
however, findings also indicated enterocin 1146 production improved with the use of sucrose. 
Cheigh et al. (2002) tested the effect of many different carbon sources on bacteriocin production 
by a strain of Lactococcus lactis in M17 broth, including glucose, lactose, sucrose, xylose, 
fructose, galactose, arabinose, and raffinose. Utilization of lactose as a carbon source was most 
successful in this study. While carbon source is important for bacteriocin production, the limiting 
factor for bacteriocin production appears to be organic nitrogen sources. Kim (1997) found nisin 
concentration has a positive correlation with organic nitrogen concentration in media. The 
previously mentioned study by Cheigh et al. (2002) also studied variations in nitrogen source, 
finding the use of yeast extract to improve bacteriocin production over the other sources. 
Nisin production occurs throughout growth, but spikes late in the log phase of growth (Cheigh et 
al., 2002). Class IIa bacteriocins, on the other hand, are secreted throughout bacterial growth. 
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During the growth period, pH levels between 5.5 and 6.0 result in the highest level of bacteriocin 
production when bacteria is incubated at ideal temperatures (Cheigh et al., 2002; Parente & 
Ricciardi, 1999). Certain other compounds can enhance the production of bacteriocins as well. 
Some examples include the use of 1% ethanol, which may assist in the expression of the gene, 
and the use of Tween 80. However, the possibility exists that the use of Tween may prevent 
bacteriocin from adhering to the surface of the container in which it is produced (Parente & 
Ricciardi, 1999). 
Bacteriocin Isolation and Activity Determination 
Bacteriocin-producing LAB are quite frequent in foods. These can easily be isolated from meats, 
cheeses, and vegetables and screened for bacteriocin production. Because of their potential as 
antimicrobials in foods, it is only reasonable to source LAB from foods, as they are acclimated to 
the environment. Several different methods have been used to isolate bacteriocin-producing LAB, 
but the use of an indicator strain to observe antagonistic activity by the LAB is well-established 
and used (Barefoot & Klaenhammer, 1983; Moraes et al., 2010; Settanni & Corsetti, 2008; 
Vijayakumar, 2014). After isolation of a bacteriocin-producing colony, several methods can be 
used to determine bacteriocin production. Determination of bacteriocin activity can be performed 
by a “spot-on-lawn” assay. This requires a lawn of the indicator organism, spotted with a titer of 
the bacteriocin on the surface after drying. After incubation, activity units (AU) of the specific 
bacteriocin can be determined from the last dilution made that still displays antimicrobial activity. 
A similar procedure is the well diffusion method, which also utilizes antagonistic activity by 
adding bacteriocin to a well formed in agar. (Barefoot & Klaenhammer, 1983; Schillinger & 
Lücke, 1989). This method relies on the distance inhibition is seen within the media against the 
indicator strain. (Rodríguez et al., 2002). A final method is to screen samples for bacteriocin 
genes against a database (Henning et al., 2015a; Knoll et al., 2008). All methods have their 
benefits and drawbacks. While screening for bacteriocin genes gives comprehensive information, 
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not all bacteriocins whose genes are identified may be expressed, and this method is typically 
more involved and expensive than others. The drawback with the “spot-on-lawn” method is that 
other inhibitory components produced by the bacteria can falsely lead to the conclusion 
bacteriocin activity is present. Inhibition by hydrogen peroxide, bacteriophages, and lactic acid 
can lead to such assumptions, but proper controls can determine their involvement (Moraes et al., 
2010; Vijayakumar, 2014). 
Resistance of Listeria to Bacteriocins 
Strains of Listeria monocytogenes can develop resistance to bacteriocins naturally, which is a 
subject of concern if bacteriocins are to be used as natural antimicrobials in foods (Ennahar et al., 
2000a). While class I bacteriocins display activity against Listeria, resistant colonies have been 
shown to occur at a frequency of between 10-5 and 10-8 (Bouttefroy & Millière, 2000). In fact, 
resistance is estimated to occur in 1 to 8% of wild Listeria strains (Gravesen et al., 2002). 
Microorganisms can incur resistance by cutting the bacteriocin peptide, or by utilizing efflux 
pumps, but in L. monocytogenes, spontaneous resistance can also occur by gene mutations, 
resulting in adjustment of the fatty acid content in the cell membrane. By changing the fatty acid 
composition, bacteriocins have less affinity for the new molecule and therefore do not bind 
successfully to the membrane of the target cell; (Crandall & Montville, 1998; Maisnier-Patin & 
Richard, 1996). This change is evident with the development of nisin resistance by Listeria, as 
resistance occurs more frequently with changes in the cell membrane. Evidence of this includes 
decreased flexibility and negative charge of the Listeria membrane, caused by modifications in 
the cell membrane (Bouttefroy & Millière, 2000). Interestingly, as mentioned by  Bouttefroy and 
Millière (2000), at low temperatures of 10°C, a 2% concentration of salt seemed to inhibit the 
antagonistic effect of nisin against Listeria (2000). Gravesen et al. (2002) mentions nisin 
resistance occurs gradually with increasing concentrations and suggests that resistance to the class 
IIa bacteriocin, pediocin, occurs naturally in certain Listeria strains. While this is concerning, it 
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has also been shown that growth of Listeria strains in the absence of bacteriocins can result in 
loss of resistance after several generations (Dykes & Hastings, 1998). In spite of the issues 
presented by the formation of resistant strains, Gravesen et al. (2002) found that the lag phase 
growth period increased and growth rate decreased for resistant strains tested, suggesting 
something less than complete resistance. One important point also worth noting is resistance to 
one bacteriocin does not mean a strain of Listeria is resistant to all bacteriocins, but rather, as 
discussed by Macwana and Muriana (2011), this indicates the strain is resistant to bacteriocins 
specifically operating by that mode of action. 
Problems with Bacteriocins in Food Applications  
Application of the actual bacteriocins into foods can also present complications. When 
bacteriocin is incorporated into a food matrix, its amphiphilic nature becomes problematic, and it 
binds to food constituents, leaving less bacteriocin free to bind with L. monocytogenes. Another 
issue has presented itself regarding the use of bacteriocin-producing bacteria as one component of 
multi-strain starter cultures. Some starter cultures may not be resistant to the bacteriocin or the 
bacteriocin-producing strain added, and therefore may affect the flavor of the final product. Also, 
by using live bacteriocin-producing cultures alongside other starter cultures, the levels of 
bacteriocin-producing cultures may not reach levels high enough to achieve a significant 
reduction in Listeria. 
Studies with Listeria Inhibition by Bacteriocins 
Because LAB are found naturally in foods, the use of bacteriocins as protective cultures or cell-
free supernatants (CFS) has been the focus of food research in recent years, particularly in meats 
and cheeses. It has been found that in cooked or pasteurized products the lack of background 
bacteria allows for an opportunistic environment for L. monocytogenes, should the food become 
contaminated (Gombas et al., 2003). By applying cultures which produce bacteriocins, a 
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protective antimicrobial effect may be achieved. In a study on sausages by Budde et al. (2003), 
the use of a protective culture of Leuconostoc carnosum 4010 resulted in a level of Listeria less 
than 10 CFU/g in sausage slices after 28 days, in comparison with the control, which yielded 108 
CFU of L. monocytogenes at the end of the sampling period.  
In another study, the use of bacteriocin from an Enterococcus spp. culture paired with nisin 
successfully inhibited growth of Listeria in ham, though sodium lactate was also applied, so the 
pure effect of the bacteriocin was not quantified (Du et al., 2017). An assay in raw pork showed 
use of LAB cultures lowered L. monocytogenes counts for several weeks, followed by return to 
normal growth (Kouakou et al., 2010). This issue is mirrored in several other studies (Bouttefroy 
& Millière, 2000; Murray & Richard, 1997).  
 Addition of CFS has been a subject of research as well. By adding CFS, the issue the 
questionable safety of bacteriocin-producing strains is less of a concern, however the absence of 
culture may not contribute to a product’s preferred flavor profile. Many studies have looked at the 
use of CFS, including one focusing on the use of the bacteriocins on pork shoulder cuts. After dip 
inoculation with approximately 107 CFU/mL Listeria solution, counts were reduced for two days 
before growth resumed with comparable rates to the control (Murray & Richard, 1997). While 
results seem undesirable, levels of 107 CFU/mL are not levels typically observed when products 
are contaminated in industry, which are typically no higher than 103 CFU/g (Gnanou Besse et al., 
2008). When observing the effect of CFS in various food models, Hartmann et al. (2011) found 
Sakacin X bacteriocin better inhibited L. monocytogenes growth in milk, while Sakacin A better 
inhibited the pathogen in ground beef models. This stresses the importance of testing bacteriocins 
in the foods to which they are to be applied prior to commercial application, as results vary and 




Of course, for prevention of Listeria growth, the addition of LAB or CFS in addition to other 
measures would help improve effectiveness. This may include pairing with organic salts, such as 
sodium lactate and diacetate, which are currently used in industry (Maks et al., 2010; Wan 
Norhana et al., 2012). Nisin has also been shown to have increased efficacy against Gram-
negative bacteria when paired with EDTA or other chelators (Stevens et al., 1991; Wan Norhana 
et al., 2012). 
Use of Frankfurters as a Model for Bacteriocin Action Against Listeria monocytogenes 
Chan and Wiedmann (2008) emphasized the importance of proper storage temperatures on 
preventing the growth of L. monocytogenes in hotdogs, mentioning the lag phase time in hotdogs 
drastically decreases from 18 days at 4.4ºC to 6.5 days when stored at 10ºC. The ease with which 
the pathogen can accumulate in this product makes frankfurters an ideal environment in which to 
study the effect of bacteriocins against L. monocytogenes.  
Nieto-Lozano et al. (2010) formulated a pork and beef formulation of hotdogs without any 
additional antimicrobials for use in comparing the effect of the CFS of a pediocin-producing 
strain of Pediococcus acidilactici against a single strain of L. monocytogenes at 4°C and 15°C. 
After being submerged in 5,000 AU CFS for 10 minutes, they were then immersed in 5.3 log 
CFU/mL L. monocytogenes CECT4031 before packaging and incubation. The study found that 
after 60 days incubation at 4°C, a 2-log CFU/g difference in Listeria between the control and the 
CFS-treated packages, containing 5.9 log CFU/g and 3.9 log CFU/g, respectively. At abuse 
temperature (15°C), the inhibition effect was not significant, as a difference of only 0.6 log 
CFU/g was observed.  
Another study conducted by Chen et al. (2004) observed the effect of ALTA™ 2341 from Quest 
International, a commercial product containing pediocin, against L. monocytogenes in 
frankfurters. The beef/pork blend of hotdogs were formulated without additional antimicrobials, 
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and the equivalent amount of 3000 or 6000 (depending on the batch) AU of ALTA™ 2341 was 
applied to the hot dogs, followed by inoculation of 5.2 log CFU/g or 3.2 log CFU/g of a 5-strain 
blend of L. monocytogenes. Frankfurters were stored at 2-4°C for 14-18 hours. At low inoculation 
levels, results indicated a 1.5-1.8 log CFU/g reduction, while the high inoculation gave a 1.6-2.1 
log CFU/g reduction. 
Finally, the effect of a multiple mode of action (MOA) bacteriocin cocktail on hotdogs was 
analyzed by Vijayakumar and Muriana (2017). In this study, bacteriocins were separated by 
MOA and selected for a cocktail of CFS. Several different batches were tested, including the 
replacement of the water with 300 µL CFS within the hotdog formulation, CFS applied as a 
surface antimicrobial, and the application of CFS on casings prior to peeling. Hot dogs of each 
batch were treated with 100 µL of 4.0 log CFU/mL L. monocytogenes, prior to incubation at 5°C. 
After 12 weeks, frankfurters that had bacteriocin added in place of water showed a 5 log CFU/mL 
difference from the control, while the bacteriocin sprayed on casings prior to peeling showed an 
approximately 2 log CFU/mL difference, and the surface application of bacteriocin to the hotdogs 
gave an approximately 7 log CFU/mL difference from the control.  
All these studies indicate the use of bacteriocin in frankfurters effectively inhibits the growth of 
L. monocytogenes. Further studies characterizing the effect of multiple MOA bacteriocins over 
the entirety of a frankfurters shelf life, analysis of different application procedures, and 
comparison of bacteriocins with commercial antimicrobials would establish an understanding for 
the practicality of their use in industry. 
Objectives of This Study 
The aim of this study was to improve the understanding of multiple MOA bacteriocin use in RTE 
meats. To meet this goal, several objectives were met. First, grouping of bacteriocins by MOA, 
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the isolation and characterization of additional bacteriocin-producing strains, and finally, the 
development and utilization of a multiple MOA bacteriocin cocktail in hotdogs.  
The first objective was met by screening bacteriocin cultures within the laboratory collection with 
a strain of L. monocytogenes, using the process described by Macwana and Muriana (2011). This 
process worked by generating a strain of L. monocytogenes resistant to one bacteriocin, and thus 
cross-resistant to bacteriocins utilizing the same MOA. The process was repeated with other 
bacteriocins using the new resistant strain, allowing for accumulated resistance to all bacteriocins 
within the laboratory collection. By screening bacteriocins for MOA, the strains of LAB chosen 
for use in applications could be selected by bacteriocin utilization of different MOA to avoid the 
formation of spontaneously resistant Listeria strains. 
To achieve the second goal, the most resistant strain of L. monocytogenes was used to screen 
animal-sourced samples for bacteria producing bacteriocins, using the method described by 
Henning et al. (2015b), then isolated bacteria were identified. Bacteriocins considered for 
utilization in a bacteriocin cocktail were screened for virulence factors, including gelatinase and 
hemolysin. 
Finally, using information gathered about the bacteriocins and their bacteria within the laboratory 
collection, strains were selected to develop a multiple MOA bacteriocin cocktail. Cell-free 
supernatant (CFS) from each strain were combined and used in 20-week long shelf life studies 
against L. monocytogenes. Three studies in frankfurters were conducted; two comparing the 
effectiveness of addition of the bacteriocin cocktail developed in this study, the bacteriocin 
cocktail described in Vijayakumar (2014), and two commercial antimicrobials at both high and 
low inoculum levels. The third study analyzed various applications of bacteriocin cocktails to the 







CHARACTERIZATION OF LACTIC ACID BACTERIA BASED ON BACTERIOCIN 
MODE OF ACTION 
 
ABSTRACT 
Bacteriocins produced by lactic acid bacteria (LAB) can inhibit the growth of Listeria spp. 
Previous work (Macwana & Muriana, 2011) identified that isolated bacteriocin-resistant strains of 
Listeria monocytogenes show cross-resistance to other bacteriocins; these bacteriocins were 
considered to possess the same mode-of-action (MOA). However other bacteriocins assumed to 
be utilizing different MOAs still inhibited the bacteriocin-resistant strain. As additional 
bacteriocin-resistance was incurred on top of the previously-acquired resistances with 
bacteriocins of a different MOA, the strain with multiple-bacteriocin-resistance served as a 
bacterial screen for our search of bacteriocins possessing new MOAs. 
Objectives of this work included a) screening for bacteriocin-producing bacteria expressing rare 
MOA bacteriocins, b) analyzing non-traditional LAB for presence/absence of putative virulence 
factors, and c) analyzing mixtures of MOAs to obtain the best bactericidal activity against 
Listeria. Samples were screened for bacteriocins expressing antagonistic effects against L. 
monocytogenes 39-2 R0 and our multiple-bacteriocin resistant strain of L. monocytogenes 39-2 
(R3), which was used to screen bacteriocin-producing LAB for bacteriocins expressing rare 
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MOA. Organisms producing such bacteriocins were identified using 16s rRNA PCR and 
sequence analysis.  
Prior to application in a bacteriocin cocktail, enterococcal strains were tested for hemolysin and 
gelatinase activity as potential virulence factors, and mixtures of different MOA bacteriocins were 
analyzed for activity against L. monocytogenes.   
From this study, 6 isolates were inhibitory to L. monocytogenes 39-2 R0, of which only 2 
(Streptococcus spp. 323, Streptococcus spp. 707) were inhibitory to L. monocytogenes 39-2 R3, 
which was resistant to bacteriocins representing 3 different modes of action. These 2 bacteriocins, 
therefore, represent a unique (4th) mode of action. From 20 Bac+ Enterococcus strains tested, only 
four strains of Enterococcus faecalis (BJ-12, BJ-13, BJ-19, and BJ-27) produced gelatinase, while 
none of these strains displayed hemolysin activity on horse blood agar in comparison to a 
hemolysin-producing control strain. 
Because bacteriocin resistance can occur against individual bacteriocins, later studies will address 




Listeria monocytogenes is a pathogen of concern in ready-to-eat (RTE) foods and has been the 
cause of many recalls and illnesses, including outbreaks with cheese, ice cream, and cantaloupe 
(Center for Disease Control and Prevention, 2018b). Listeria is a ubiquitous organism and can be 
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found in the environment, but often gains access to food systems because of poor sanitation or 
post-processing contamination. For this reason, hotdogs are particularly high risk foods for 
Listeria contamination. Within the industry, measures are taken to prevent growth of the 
pathogen, such as the addition of lactates and diacetates; however, consumers in recent years have 
initiated a movement for less processed, naturally-derived products from the food industry. To 
comply with consumer demands, natural intervention strategies have been more greatly desired 
and researched. 
One potential natural intervention is the use of bacteriocins from LAB as antimicrobials. Lactic 
acid bacteria are Generally Recognized as Safe (GRAS) due to their history of safe use in a wide 
variety of food products, which logically led to researching bacteriocins for use in foods as 
antimicrobials. A variety of studies have been conducted with these antimicrobial peptides, 
including research in cheese (Dal Bello et al., 2011), ham (Du et al., 2017), wine (Díez et al., 
2012), and hotdogs (Chen et al., 2004; Vijayakumar & Muriana, 2017).  A variety of different 
bacteriocin application procedures have been examined, from direct addition of the bacteriocin-
producing cultures to the addition of cell-free supernatant (CFS) and purified bacteriocin. 
Nisin and pediocin have been used in commercial products, Nisaplin® and ALTA 2341™, 
respectively. While these both display antagonistic effects against L. monocytogenes, the 
pathogen also can develop spontaneous resistance. To best avoid this issue from occurring, 
combining bacteriocins employing different MOAs creates additional hurdles for Listeria to 
overcome, and makes resistant strains less likely to occur. Another solution would be pairing 




The use of multiple MOA bacteriocin cocktails has been previously researched by Vijayakumar 
and Muriana (2017), but to our knowledge no studies have compared the effectiveness of a 
multiple MOA bacteriocin cocktail to commercially sold natural antimicrobial solutions, which 
would better address their potential for use within the food industry.  
With this in mind, the objectives of this research were to screen bacteriocins by MOA using the 
method described by Macwana and Muriana (2011), screen samples for the presence of a 
bacteriocin employing a unique, rare MOA using a multiple bacteriocin-resistant L. 
monocytogenes strain, identify any virulence factors that may be present in bacteriocin-containing 
CFS, and develop a bacteriocin cocktail for later applications in hotdog shelf-life challenge 
studies where the effectiveness of the cocktail will compared to that of several commercial 





MATERIALS AND METHODS 
Preparation of Cultures for Use in Studies 
Master cultures of bacteriocin-producing lactic acid bacteria (LAB) and Listeria monocytogenes 
from the Muriana culture collection were stored at -80°C in milk-based freezing medium 
containing 11% non-fat dry milk, 1% glucose, and 0.2% yeast extract. Working stocks of cultures 
were made by inoculating 9 mL of either MRS (for LAB cultures) or TSB (for L. monocytogenes 
cultures) broths with 100-µL of culture and growing overnight for 16 hours at 30°C. These were 
then streaked for isolation, and a single colony was selected and grown 16 hours before preparing 
cultures for freezing. Cultures were centrifuged at 8000 rpm in a Sorvall® RC 5C Plus centrifuge 
with a SS-34 rotor for 10 minutes at 4°C, supernatant was decanted, and the remaining pellet was 
resuspended in the milk-based freezing medium previously described for storage at -80°C. From 
these working cultures, bacteria needed for studies were propagated twice overnight for 16 hours 
before use. 
Table 2.1. Cultures used in this study 
Microorganism Strain Designation Source/Reference 
Listeria monocytogenes  39-2 R0; not bacteriocin resistant Muriana Culture Collection 
Listeria monocytogenes  39-2 R1; not resistant to 56, FLS-1, 323 This Study 
Listeria monocytogenes  39-2 R2; not resistant to FLS-1, 323 This Study 
Listeria monocytogenes  39-2 R3; not resistant to 323 This Study 
Lactobacillus curvatus FS47 Garver and Muriana (1993) 
Enterococcus faecium FS97-2 Henning et al. (2015a) 
Lactococcus lactis FLS-1 Vijayakumar (2014) 
Enterococcus faecium FS56-1 Garver and Muriana (1993) 
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Pediococcus acidilactici Bac 3 Muriana Culture Collection 
Streptococcus spp. 707 This Study 
Streptococcus spp. 323 This Study 
Enterococcus durans FS707 Henning et al. (2015b) 
Enterococcus faecalis BJ-12 Henning et al. (2015b) 
Enterococcus faecalis BJ-13 Henning et al. (2015b) 
Enterococcus faecalis  BJ-19 Henning et al. (2015b) 
Enterococcus faecalis  BJ-27 Henning et al. (2015b) 
Enterococcus faecium 326F Henning et al. (2015b) 
Enterococcus faecium FS56-1 Henning et al. (2015b) 
Enterococcus faecium FS97-2 Henning et al. (2015b) 
Enterococcus faecium JCP B-5 Henning et al. (2015b) 
Enterococcus faecium JCP M-2 Henning et al. (2015b) 
Enterococcus faecium JCP-9 Henning et al. (2015b) 
Enterococcus faecium Milk 5 Henning et al. (2015b) 
Enterococcus faecium Milk 12 Henning et al. (2015b) 
Enterococcus faecium NP-7 Henning et al. (2015b) 
Enterococcus faecium Poop4 Henning et al. (2015b) 
Enterococcus faecium THYME2 Henning et al. (2015b) 
Enterococcus faecium THYME3 Henning et al. (2015b) 
Enterococcus hirae 323F Henning et al. (2015b) 
Enterococcus thailandicus FS92 Henning et al. (2015b) 
Enterococcus thailandicus RP-1 Henning et al. (2015b) 
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Preparation of Bacteriocin-Containing Cell Free Supernatant of Lactic Acid Bacteria Cultures 
After growth for 16 hours, bacteriocin-producing LAB cultures were centrifuged at 10,000 rpm in 
a Sorvall® RC 5C Plus centrifuge with a SS-34 rotor for 10 minutes, followed by the separation 
of the supernatant and pellet. Supernatant in volumes of 9-mL were pasteurized in a water bath at 
80°C for 15 minutes to eliminate any remaining cells.  Because the bacteriocins belong to heat-
stable class IIa bacteriocins, pasteurization should had no effect on antagonistic activity towards 
L. monocytogenes.  
Preparation of Listeria monocytogenes 39-2 Strains for use in Bacteriocin Screening 
Using the method described by Macwana and Muriana (2011), strains of increasingly resistant L. 
monocytogenes 39-2 were generated. To accomplish this, 1-mL of cell-free supernatant (CFS) 
from Lactobacillus curvatus FS97 was applied to a plate of TSB with 1.5% agar. Full-strength L. 
monocytogenes 39-2 R0 (non-resistant) culture was then spread plated on top and incubated at 
30°C until resistant colonies appeared. This new FS97 (Lb. curvatus) resistant strain, heretofore 
referred to as R1, was then used to screen bacteriocins within the laboratory collection for 
activity. Bacteriocins to which this new L. monocytogenes 39-2 R1 was resistant, were identified 
as having the same MOA as the Lactobacillus curvatus FS97 bacteriocin.  
Listeria monocytogenes 39-2 R1 was then in turn used to create another, more compounded 
resistant strain. This was done by repeating the same process as before, but instead applying the 
CFS from Enterococcus faecium FS56-1, which still displayed antagonistic activity against the R1 
strain, to tryptic soy agar (TSA) and spread plating undiluted L. monocytogenes 39-2 R1 onto the 
surface. This was again incubated at 30°C until resistant colonies appeared. This new isolate then 
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was labeled as L. monocytogenes 39-2 R2 and exhibited resistance against both Lb. curvatus FS97 
and En. faecium FS56-1.  
After screening the R2 strain of Listeria against bacteriocins within our collection, bacteriocin 
from Lactococcus lactis FLS-1 still displayed antagonistic activity. Using the same procedure 
previously used to obtain resistant Listeria, additional resistance was incurred to this bacteriocin 
to develop a strain of Listeria monocytogenes 39-2 R3. No bacteriocins within the lab culture 
collection displayed resistance to the R3 isolate. 
 
Screening of Animal-Sourced Samples for Novel Mode of Action Bacteriocins  
The previously mentioned method of separating bacteriocins based on mode of action (MOA) 
resulted in the development of a strain of L. monocytogenes 39-2 with resistance to all 
bacteriocins within our laboratory collection (L. monocytogenes 39-2 R1, R2, R3). The L. 
monocytogenes 39-2 R3 strain was used to screen bacteria from bovine samples (Guillen, 2009) 
for a lactic acid bacterium producing a bacteriocin operating by a different MOA.  
Each animal-sourced sample was tested twice, once after enriching samples overnight for 16 
hours in De Man, Rogosa, and Sharpe (MRS) Medium, and again by plating direct dilutions of 
the sample. The goal of screening samples without enrichment was to identify bacteria that may 
otherwise be outpaced by fast-growing bacteria during enrichment.  
A series of ten-fold dilutions were made of each sample, using 0.1% Buffered Peptone Water 
(BPW) and spread plated. Then an overlay of MRS medium with 1.5% agar was applied followed 
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by a 24-hour incubation period. Tryptic Soy Broth (TSB) with 0.75% agar was prepared, and L. 
monocytogenes 39-2 R3 was added to the mixture, resulting in a concentration of approximately 
106 CFU/mL. The agar was applied to the plates that had incubated whereupon the plates were 
subjected to another 24-hour incubation period. A large clear zone surrounding a colony 
tentatively indicated the inhibition of L. monocytogenes growth by a bacteriocin-producing 
bacterium. Bacterial isolates were recovered by inverting agar layers into the petri plate cover, 
excising agar surrounding a presumptive bacteriocin-producing colony, and isolating with a 
flame-sterilized loop. This process is shown in Figure 2.1, obtained from Henning (2016). To 
ensure the presence of bacteriocin activity, isolates were streaked for purity, and a single colony 
was chosen, then patch plated on two separate plates. One of the patch plates was directly 
overlain with TSA soft agar laced with L. monocytogenes at an approximate concentration of 106 
CFU/mL, while the other plate had no further treatment applied. Both plates incubated at 30°C 
overnight and presence or absence of bacteriocin activity was recorded the following day. Isolates 
with confirmed bacteriocin activity were collected from the untreated plate with a flame-sterilized 








































Figure 2.1. Isolation of bacteriocin-producing bacteria – taken from Henning (2016). 
 
Isolate Identification and Characterization 
Extraction of Bacterial DNA 
Prior to identification of bacterial isolates from screening using 16s rRNA PCR, bacterial DNA 
had to be extracted. First, bacteria were grown at 30°C for 16 hours before extraction. Cultures 
were vortexed to ensure the homogenization of the mixture, and 1.4-mL were transferred to a 1.5-
mL Eppendorf microcentrifuge tube. Contents were centrifuged at 12,000xg in an Eppendorf 
5424 centrifuge for 90 seconds and supernatant was discarded. A total of 500 µL of deionized 
water (DI) was added to the tube, and the contents were vortexed to resuspend the pellet. Samples 
were centrifuged again at 12,000xg for 90 seconds, before discarding the supernatant and 
repeating the same step with another 500-µL of DI water.  
After the second wash with DI water, the supernatant was manually pipetted and discarded. This 
was done to avoid disrupting the pellet. Preparation of DNA was performed by the bead collision 
method described by Coton and Coton (2005). Depending on the size of the resulting pellet, 100-
120-µL of 10 mM Tris buffer at pH 7.4 was added. After resuspension, sterile silica beads were 
added, then samples were subjected to several rounds alternating between vortexing and cooling 
on ice, intended to shear cells and expose the contents within the cell. After a final cooling period, 
samples were centrifuged at 12,000xg for 2 minutes. The supernatant containing the extracted 
DNA was then pipetted and added to another sterile microcentrifuge tube before placing the 
sample on ice to prevent DNAses from damaging the product. 
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Identification of Bacteriocin-Producing Isolates 
After extraction of DNA, samples could be identified using PCR. Each sample for analysis was 
allotted to a sterile 200-µL flat-capped PCR tube containing the components required for 
amplification (Table 2.3). 
 












The mixture was placed in a BioRad iCycler MyIQ™ Optics (thermal cycler), where 
amplification of each sample ensued alongside a positive (DNA previously extracted) and 
negative (water in place of DNA) control. Primers included 515F (5’-
GTGCCAGCMGCCGCGGTAA-3’) and 1391R (5’GACGGGCGGTGTGTRCA-3’) previously 
Component Volume 
Nuclease Free DI Water 11.75µL 
DNA 1µL 
Forward Primer (515F) 2µL 
Reverse Primer (1391R) 2µL 
Taq Polymerase 1.25µL 
dNTP 0.5µL 
5X GoTaq Flexi Buffer 5µL 




used by Henning et al. (2015). An initial denaturation at 95°C was followed by 40 cycles 
consisting of denaturation at 94°C for 1 minute, 58°C for 45 seconds to allow for annealing, and 
extension at 72°C for 1 minute. The process concluded with a final extension step at 72°C for 4 
minutes, followed by cooling to 4°C.  
The resulting amplification product was purified using Wizard® SV Gel and PCR Clean-Up 
System (Promega, Madison, Wisconsin). Agarose gel electrophoresis of PCR products was 
performed using 1.6% (wt/vol) agarose gel with added ethidium bromide (for visualization) 
running at 80V on a BioRad PowerPac power supply, with a 1000-bp DNA ladder to aid in size 
identification of the amplimers. A BioRad ChemiDoc™ XRS transilluminator was used to view 
bands and verify the correct size of product, which was approximately 900-bp. A slice of the gel 
containing the band of DNA was excised from the gel and weighed in a 1.5-mL Eppendorf 
microcentrifuge tube in order to extract DNA from the gel. For purification of the DNA from this 
sample, the Promega Wizard® SV Gel and PCR Clean-Up System was used, beginning with the 
addition of the kit’s membrane binding solution added in an amount of 10-µL/mg to the gel slice. 
Contents were vortexed and placed in a 60°C water bath until the gel had dissolved 
(approximately 10 minutes). The contents were again vortexed and transferred to a minicolumn, 
which was set into a 1.5-mL microcentrifuge tube. The melted gel solution and minicolumn were 
incubated at room temperature for one minute to allow for product to bind to the column. The 
minicolumn was then centrifuged at 12,000xg in an Eppendorf 5424 centrifuge for one minute, 
and contents which had passed through the column were disposed. A 700-µL aliquot of wash 
buffer was applied to the minicolumn and centrifuged at 12,000xg for 1 minute, then flowthrough 
discarded. The same step was repeated with 500-µL of wash buffer. The column was centrifuged 
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again, then the minicolumn was transferred to a sterile microcentrifuge tube. Nuclease-free water 
(50-µL) was added to the column and allowed to sit at room temperature for 1 minute to allow 
product to elute into the water. The column was centrifuged a final time for 1 minute at 12,000xg, 
then the eluate was frozen at -20°C until submission for sequencing at the Oklahoma State 
University Core Facility. 
Protease Assay 
Confirmation of the proteinaceous character of the bacteriocin was performed by addition of 20-
µL of Pronase E (Sigma-Aldrich, St. Louis, Missouri) containing 1060-AU/mL to 80-µL of 
bacteriocin preparation and incubation of the mixture for 1 hour at 30°C. Loss of activity 
determined by a spot-on-lawn assay against L. monocytogenes 39-2 confirmed the proteinaceous 
nature of the bacteriocin. 
Catalase Assay 
Production of hydrogen peroxide by LAB occurs and can inhibit the growth of other organisms, 
so a catalase assay was performed to ensure hydrogen peroxide was not responsible for the 
observed inhibition of L. monocytogenes. For this assay, 20-µL of catalase (14,600 AU/mL, 
AMRESCO, Dallas, Texas) was applied to 80-µL of bacteriocin preparation and incubated for 1 
hour at 30°C. Household hydrogen peroxide (3%) was used as a control. After a spot-on-lawn 
assay, loss of inhibitory activity indicated the presence of catalase. 
 Bacteriocin Quantification 
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Quantification of bacteriocin activity from isolates was performed by a “spot-on-lawn” assay as 
described by Henning et al. (2015a). Cell-free supernatant (CFS) was added to a 96 well plate and 
serially diluted two-fold until a series of 16 dilutions were obtained. A petri plate was scored into 
8 sections with a marker and overlaid with TSA and 0.75% agar (i.e. “soft agar”) containing 
approximately 106 CFU/mL L. monocytogenes 39-2 R0. After allowing the seeded agar media to 
solidify, 5-µL of the 2-fold dilutions were allocated to each section of the plate. Plates were 
incubated at 30°C for 24 hours, and bacteriocin strength was determined from the last dilution 
still showing inhibitory activity (1/(200 x 2x),  x=number of dilutions performed). 
Screening of Bacterial Isolates for Virulence Factors 
Concerns with Streptococcus and Enterococcus spp. potentially being opportunistic pathogens 
suggest cautious use of live strains of such bacteria in food applications should only be done after 
testing for the absence of potential virulence factors. Despite the fact that CFS was to be used in 
our work, characterization of the strains used within the bacteriocin cocktail was still be 
performed to alleviate any concerns. Production of hemolysin and gelatinase were tested in 
bacteriocin-producing Enterococcus spp. strains. Hemolysin was tested by the method described 
by Upadhyaya et al. (2010), which involved plating strains on brain heart infusion (BHI) agar 
supplemented with 5% horse blood and incubating at 37°C for 24 hours. Zones with clearing 
indicated β-hemolysis of the blood. For gelatinase production, samples were tested using the 
method described by Furumura et al. (2006). Strains were plated on TSA with 3% gelatin and 
incubated at 37°C for 24 hours. Zones of turbidity surrounding colonies indicated the presence of 
gelatinase. 
Purification of Bacteriocin from Streptococcus spp. 323. 
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Ammonium sulfate precipitation 
The bacteriocin from the Streptococcus spp. 323 isolate was chosen for further characterization 
and identification, as the bacteriocin displayed more activity than the unique MOA bacteriocin 
originating from the other bacterium isolated from animal-sourced samples. After centrifuging 
and pasteurizing CFS from Streptococcus spp. 323 that had grown overnight, the Streptococcus 
spp. 323 bacteriocin was precipitated by ammonium sulfate fractionation. Ammonium sulfate was 
added to CFS from overnight culture to achieve a 20% saturation. This was stirred overnight at 
4°C, then centrifuged at 4500 rpm in a Sorvall® RC 5C Plus centifuge with a SLA-1500 rotor for 
30 minutes. The supernatant was decanted and recovered from the pellet and then brought to 30% 
ammonium sulfate saturation. This was again stirred overnight at 4°C before centrifuging. The 
resulting pellet from the 30% ammonium sulfate saturation was resuspended in 4-mL of 1X PBS 
buffer and subjected to a titer assay against L. monocytogenes 39-2 to determine the recovery 
level of bacteriocin activity. The remaining supernatant from the 30% ammonium sulfate fraction 
was then brought to 40% saturation and the same process repeated stirring this fraction overnight 
and centrifuging and resuspending the resulting pellet in 1X PBS buffer. The bacteriocin activity 
of this fraction was also determined using a titer assay. 
C18 Sep-Pack elution 
Further purification of CFS containing bacteriocin was necessary for identification of the specific 
bacteriocin from Streptococcus spp. 323. The resuspended pellet (4-mL, 12,800 AU) from the 
ammonium sulfate fractions were applied to a primed C18 solid phase extraction column 
(BAKERBOND™ Octadecyl (C18) Disposable Extraction Columns, JT Baker, Phillipsburg, NJ). 
The product bound to the column was then subject to fractionation with 4-mL isopropanol using 
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percentages of 0% (water), 25%, 50%, 75%, and 100%. Fractions were freeze-dried, then 
resuspended with 1-mL sterile DI water. Resulting solutions were subjected to a two-fold dilution 
titer assay against L. monocytogenes to determine the level of activity recovered. Protein amounts 
present in each step of the purification process were measured with a Nanodrop ND-1000 
spectrophotometer at 280-nm and bacteriocin activity measured in each fraction by a two-fold 
dilution titer assay.  
HPLC Chromatography 
Samples recovered from ammonium sulfate and C18 cartridge fractionation were further purified 
by high-performance liquid reversed-phase chromatography (HPLC) on an Agilent/HP 1050 
system consisting of a quaternary pump (79852A), a diode array detector (G1306A), an 
autosampler (79855A), and a solvent degasser. Separation was performed on a 250 x 4.6 mm 
Kromasil (3.5μ) C4 column (PN 0497; Brewster, NY, USA) using a gradient of 19.25% to 81% 
Acetonitrile (Fisher Scientific, Raleigh, N.C.). Buffer A was made up as 5% (vol/vol) acetonitrile 
in 0.1% trifluoroacetic acid (Sigma); buffer B was composed of 95% (vol/vol) acetonitrile in 
0.05% trifluoroacetic acid. The gradient consisted of a 70-min linear gradient from 85% A/15% B 
to 20% A/80% B at a flow rate of 0.5-ml/min. Fractions were collected in 1.5-ml Eppendorf tubes 
in 1-mL increments every 2 minutes using a Bio-Rad fraction collector (Model 2128, Hercules, 
CA) and evaporated overnight on a vacuum centrifuge (Savant Instruments, Inc., Farmingdale, 
N.Y.), then resuspended in 100-µl of glass-distilled water. Resuspended fractions (5-µL) were 
spotted onto an indicator lawn of L. monocytogenes 39-2 R0 and incubated at 30°C overnight to 




Fractions subjected to HPLC and showing bacteriocin activity were submitted to the Oklahoma 






RESULTS AND DISCUSSION 
 
Preparation of Listeria monocytogenes 39-2 Strains for use in Bacteriocin Screening 
The method of characterizing bacteriocins based on MOA as used and discussed by Macwana and 
Muriana (2011) was chosen for use in this study. The wild-type strain of Listeria monocytogenes 
39-2 was sensitive to all bacteriocins to which it was exposed. These included bacteriocins 
produced by LAB strains Lactobacillus curvatus FS47, Lactobacillus curvatus FS97, 
Pediococcus acidlactici Bac 3, Lactococcus lactis FLS-1, and Enterococcus faecium FS56-1. 
When L. monocytogenes 39-2 spontaneously gained resistance to the Lactobacillus curvatus FS97 
bacteriocin, resulting in L. monocytogenes 39-2 R1, it also demonstrated cross-resistance to 
bacteriocins produced by Lactobacillus curvatus FS47 and Pediococcus acidilactici Bac3.  
Additional resistance gained by L. monocytogenes 39-2 R1 against the Enterococcus faecium 
FS56-1 bacteriocin, resulting in L. monocytogenes 39-2 R2, which now demonstrated resistance to 
Lb. curvatus FS97, Lb. curvatus FS47, P. acidilactici Bac3, and E. faecium FS56-1. The final 
application of bacteriocin from Lactococcus lactis FLS-1 to L. monocytogenes 39-2 R2 yielded a 
strain of Listeria (R3) fully resistant to the full repertoire of bacteriocins within the lab collection, 
representing 3 MOA, against which the L. monocytogenes 39-2 based strains were tested. The L. 
monocytogenes 39-2 (R0, R1, R2, R3) isolates were used to screen for bacteriocins demonstrating a 






















Figure 2.2. Series of bacteriocin-resistant variants of Listeria monocytogenes 39-2. Bacteriocin-
containing cell-free supernatants (Lactobacillus curvatus FS47, Lactobacillus curvatus FS97, 
Pediococcus acidlactici Bac 3, Lactococcus lactis FLS-1, Enterococcus faecium FS56-1, and 





monocytogenes R1 (Panel B), L. monocytogenes R2 (Panel C), and L. monocytogenes R3 (Panel 
D). 
 
Screening of Animal-Sourced Samples Utilizing Novel Mode of Action Bacteriocins  
Formation of the series of Listeria monocytogenes 39-2 strains (R0, R1, R2, R3) allowed for 
screening of samples in search of a bacteriocin displaying a specific MOA and ultimately allowed 
the construction of a mixture of bacteriocins displaying multiple MOAs. Samples from cattle 
yielded 6 total bacteriocin-producing isolates with 2 isolates operating by a unique MOA, which 
were detected using L. monocytogenes 39-2 R3. These two isolates were labeled as 323 and 707, 
due to the names of the samples from which they were isolated, as well as AB1, AB2, AB3, and 
AB4. Samples screened for a novel MOA are listed below in Table 3.1. Isolation of bacteria 
demonstrating the rare MOA inhibitory to L. monocytogenes 39-2 R3 were only isolated by direct 
plating without enrichment suggesting a slower growth rate by these bacteria, which may be 
overwhelmed by other LAB within the samples during enrichment.  
Originally, samples were enriched for the screening process. After seeing a lack of bacteriocin-
producing isolates utilizing the MOA for which the samples were being screened, the decision 
was made to screen samples again without enrichment in the MRS broth. The use of enrichment 
would give quickly-growing bacteria an edge over slower-growing bacteria. This was also 
discussed by Henning (2016), who observed a higher number of Lactococcus lactis isolates when 







Table 2.3. Samples screened for novel MOA bacteriocin production with Listeria monocytogenes 39-2  
Animal Sample Name Sample Enrichment  Resistant Listeria 
Used 
Bacteriocin Isolated Isolate Identified 
326 S+L Rum Inf Day 0 No Enrichment R3 No − 
Enriched R3 No − 
341 S+L Rum Inf Day 0 No Enrichment R3 No − 
Enriched R3 No − 
707 Rumen Solid DFM Day 0 No Enrichment R3 No − 
Enriched R3 No − 
323 S+L AbInf Day 0 No Enrichment R3 No − 
Enriched R3 No − 
707 DFM S+L Day 0 No Enrichment R3 No − 
Enriched R3 No − 
323 Rumen Solid AbInf Day 0 No Enrichment R3 No − 
Enriched R3 No − 
341 S+L Con Day 0 No Enrichment R3 No − 
Enriched R3 No − 
326 RumInf Rumen Solid Day 0 No Enrichment R3 No − 
Enriched R3 No − 
341 Con Rumen Solid Day 0 No Enrichment R3 No − 
Enriched R3 No − 
707 DFM Rumen Liquid Day 0 No Enrichment R3 No − 
Enriched R3 No − 
341 Con Rumen Liquid Day 0 No Enrichment R3 No − 
Enriched R3 No − 
323 AbInf Fecal Day 0 No Enrichment R3 No − 
Enriched R3 No − 
341 Con Fecal Day 0 No Enrichment R3 No − 
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Enriched R3 No − 
707 DFM Fecal Day 0 No Enrichment R3 No − 
Enriched R3 No − 
326 RumInf Rumen Liquid Day 0 No Enrichment R3 No − 
Enriched R3 No − 
323 AbInf Rumen Liquid Day 0 No Enrichment R3 No − 
Enriched R3 No − 
707 DFM Sponge Day 0 No Enrichment R3 No − 
Enriched R3 No − 
323 AbInf Sponge Day 0 No Enrichment R3 No − 
Enriched R3 No − 
326 RumInf Sponge Day 0 No Enrichment R3 No − 
Enriched R3 No − 
341 Con Sponge Day 0 No Enrichment R3 No − 
Enriched R3 No − 
326 RumInf Fecal Day 0 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Fecal Day 0 No Enrichment R3 No − 
Enriched R3 No − 
323 DFM Fecal Day 0 No Enrichment R3 No − 
Enriched R3 No − 
323 Con Fecal Week 0 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Fecal Week 0 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Fecal Week 0 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Fecal Week 0 No Enrichment R3 Yes Streptococcus spp. 707 
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Enriched R3 No − 
323 Con Fecal Week 0 No Enrichment R3 Yes Streptococcus spp. 323 
Enriched R3 No − 
323 Con Rumen Liquid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Rumen Liquid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Rumen Liquid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Rumen Liquid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM S+L Week 0 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf S+L Week 0 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf S+L Week 0 No Enrichment R3 No − 
Enriched R3 No − 
323 Con S+L Week 0 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Rumen Solid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Rumen Solid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Rumen Solid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
323 Con Rumen Solid Week 0 No Enrichment R3 No − 
Enriched R3 No − 
323 Con Sponge Week 0 No Enrichment R3 No − 
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Enriched R3 No − 
326 DFM Sponge Week 0 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Sponge Week 0 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Sponge Week 0 No Enrichment R3 No − 
Enriched R3 No − 
323 Con Fecal Week 1 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Fecal Week 1 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Fecal Week 1 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Fecal Week 1 No Enrichment R3 No − 
Enriched R3 No − 
323 Con Rumen Liquid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Rumen Liquid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Rumen Liquid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Rumen Liquid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM S+L Week 1 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf S+L Week 1 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf S+L Week 1 No Enrichment R3 No − 
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Enriched R3 No − 
323 Con S+L Week 1 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Rumen Solid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Rumen Solid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Rumen Solid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
323 Con Rumen Solid Week 1 No Enrichment R3 No − 
Enriched R3 No − 
323 Con Sponge Week 1 No Enrichment R3 No − 
Enriched R3 No − 
326 DFM Sponge Week 1 No Enrichment R3 No − 
Enriched R3 No − 
707 RumInf Sponge Week 1 No Enrichment R3 No − 
Enriched R3 No − 
341 AbInf Sponge Week 1 No Enrichment R3 No − 
Enriched R3 No − 
707 Con Fecal Week 1 No Enrichment R3 No − 
Enriched R3 No − 
Ground Beef Enriched R0 Yes Lactococcus lactis AB1 
Enriched R0 Yes Lactococcus lactis AB2 
Enriched R0 Yes Lactococcus lactis AB3 
Enriched R0 Yes Lactococcus lactis AB4 
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Identification of Bacteriocin-Producing Isolates 
After bacteria producing a bacteriocin with the desired MOA were isolated, the cultures were 
grown, and DNA from the samples were extracted, amplified by PCR, purified, and sequenced. 
When sequence data was compared to the NCBI database, analysis of the 16s rRNA sequence 
data from the samples showed that both isolates found by screening with L. monocytogenes 39-2 
(R3) were streptococcal strains. The closest match for both isolates were either Streptococcus 
lutetiensis, Streptococcus infantarius, or Streptococcus equinis. All three of these had 100% 
sequence identity for the partial 16s rRNA sequence that was identified. Interestingly, both 
bacterial isolates originated from different samples, but gave similar identities. This may have to 
do with the location the isolates originated from, as these are common bacteria in cattle. Because 
these isolates may belong to Group D streptococci, virulence is an important concern that should 
be addressed, and due to this, the two isolates were tested alongside the Enterococcus spp. 
cultures in our collection for virulence factors such as hemolysin and gelatinase. Other isolates 
found in ground beef were strains of Lactococcus lactis, which are commonly found in meats. 
Moving forward with the study, samples 323 and 707 were examined more closely, as their 
unique MOA was of interest for use in a multiple MOA bacteriocin cocktail. 
Protease and Catalase Assays 
After a spot-on-lawn assay, bacteriocin showed loss of activity after treatment with pronase E, 
indicating proteinaceous nature. Treatment with catalase had no effect on the inhibition of L. 
















Figure 2.3. Bacteriocin treatments with pronase E and catalase. No treatment (Panel A) on 
Streptococcus spp. 323, Lactobacillus curvatus Beef 3 (Bac+), Pediococcus acidilactici (Bac-), 
and water compared to treatment with pronase E (Panel B). No treatment (Panel C) on 
Streptococcus spp. 323, Lactobacillus curvatus Beef 3 (Bac+), hydrogen peroxide, and water 
compared to treatment with catalase (Panel D). 
 
Determination of Bacteriocin Titer and Heat Stability 
The use of a culture supernatant as a crude bacteriocin mixture constitutes a “bacterial 
fermentate” and was practical for use as it was a cost-effective, simple method that could be 






from the supernatant to avoid any potential negative effects to any product to which it would be 
applied, as LAB can be considered spoilage bacteria. Since the bacteriocins were resistant to heat 
treatment, pasteurization of the 9-mL supernatants was performed at 80°C for 10 minutes to 
ensure the absence of any cells. The stability of class I and II bacteriocins in response to heat has 
been well-established (Chen et al., 2004; Malheiros et al., 2015; Perez et al., 2014).  Because the 
lactic acid bacteria (LAB) used in this study were heat-stable, heat pasteurization did not effect 
the antagonistic activity toward L. monocytogenes. This method was previously found to be 
equally as effective as filter sterilization (Vijayakumar & Muriana, 2017), which was also 
confirmed in this study. Heat pasteurization serves as a cheaper alternative to filtration, allowing 
for practical and cost-efficient application of these antimicrobials for commercial use in foods.  
Analysis of each bacteriocin sample in a two-fold dilution titer assay against an indicator lawn of 
Listeria monocytogenes 39-2 R0 at a concentration of approximately 106 CFU/mL showed 
Streptococcus spp. 323 (3200 AU/mL) produced more bacteriocin than Streptococcus spp. 707 
(1600 AU/mL).  While samples were not neutralized to ensure antagonistic activity against was 
not due to acid inhibition, acid inhibition is not observed when spotting 5-µL of culture 
supernatants from LAB containing no bacteriocin on Listeria (Vijayakumar & Muriana, 2015). 
Screening of Isolates for Virulence Factors 
As previously mentioned, certain non-traditional LAB, such as enterococci and streptococci 
produce virulence factors that would be of concern if products containing live bacteria were to be 
ingested by humans. Hemolysin and gelatinase, the two virulence factors for which isolates were 
tested in this study, are two common virulence factors associated with these bacterial genera 
(Franz et al., 1999; Furumura et al., 2006; Lopes et al., 2006; Upadhyaya et al., 2010). Results of 
virulence tests showed only the control organism (Enterococcus faecalis ATCC 14508) displayed 
β-hemolysis on BHI with horse blood, indicated by a clearing zone around the colonies, while 
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four of the Enterococcus spp. strains tested produced gelatinase, noted by a turbid zone 
surrounding colonies (Figure 2.4). Researchers in literature have communicated different results 
when reporting positive results of gelatinase assays, obtaining both turbid halos and clear halos 
surrounding gelatinase-positive colonies (Furumura et al., 2006; Kanemitsu et al., 2001; Vergis et 
al., 2002), however the resulting zone appearance depends on the turbidity of the media itself 
(Smith & Goodner, 1958). These results assisted in deciding which strains to include within the 
bacteriocin cocktail for RTE meat applications, allowing isolates secreting questionable 
compounds to be avoided (Table 2.4).  

















Species Strain Gelatinase Hemolysin 
Enterococcus durans FS707 − − 
Enterococcus faecalis BJ-12 + − 
Enterococcus faecalis BJ-13 + − 
Enterococcus faecalis BJ-19 + − 
Enterococcus faecalis BJ-27 + − 
Enterococcus faecium 326F − − 
Enterococcus faecium FS56-1 − − 
Enterococcus faecium FS97-2 − − 
Enterococcus faecium JCP B-5 − − 
Enterococcus faecium JCP M-2 − − 
Enterococcus faecium JCP-9 − − 
Enterococcus faecium Milk12 − − 
Enterococcus faecium Milk5 − − 
Enterococcus faecium NP-7 − − 
Enterococcus faecium Pop4 − − 
Enterococcus faecium THYME2 − − 
Enterococcus faecium THYME3 − − 
Enterococcus hirae 323F − − 
Enterococcus thailandicus FS92 − − 
Enterococcus thailandicus RP-1 − − 
Enterococcus faecalis ATCC 19433 − − 
Enterococcus faecalis ATCC 14508 − + 
Streptococcus spp. 323 − − 

















Figure 2.4. Positive and negative examples of virulence factors hemolysin and gelatinase. Panel 
A, Enterococcus faecalis ATCC 14508 displaying β-Hemolysis of horse blood. Panel B, 
Streptococcus spp. 323 showing absence of β-hemolysis. Panel C, Enterococcus faecalis BJ-19 
production of gelatinase. Panel D, Streptococcus spp. 323 showing absence of gelatinase. 
 
Purification of Bacteriocin from Streptococcus spp. 323  
Identification of the bacteriocin produced by Streptococcus spp. 323 would require the use of 
mass spectrometry, which requires the absence of detergents that cause interference when 
analyzing samples, such as Tween 80 (Jäpelt et al., 2016). To avoid this, M17 (no Tween) with 
1% glucose was used in place of MRS for growing culture with the purpose of identifying the 
specific bacteriocin produced. Although Streptococcus spp. 323 grown in M17 broth yielded less 
















bacteriocin (800 AU/mL) than with MRS broth (3200 AU/mL), we chose to continue purification 
of bacteriocin produced in M17 broth because the absence of Tween 80 would not cause 
interference during mass spectrometry analyses. Despite the difference in production of the 
bacteriocin, mass spectrometry does not require high concentrations for identification, so 
purification continued using M17 broth. 
Isolation began with saturation of cell-free supernatant (CFS) with ammonium sulfate in 10% 
increments, precipitating after each saturation level. Each supernatant recovered after 
centrifugation was then brought up to the next ammonium sulfate concentration in order to 
remove proteins precipitated at the prior level. The Streptococcus spp. 323 bacteriocin 
precipitated in the 30% and 40% ammonium sulfate fractions and were recovered after 
centrifugation. After resuspension of precipitated pellets from each of these fractions in 4-mL of 
1X PBS, these were eluted through a C18 cartridge, followed by fractionation with isopropanol 
solutions at 0% (water), 25%, 50%, 75%, and 100% concentrations. The fractions containing 
bacteriocin eluted in the 25% and 50% fractions. These fractions were then freeze-dried and 
resuspended in 1-mL DI water, resulting in further purified bacteriocin solution. The fraction with 
the highest specific activity (i.e. bacteriocin activity units per milligram of protein) present in the 
sample as determined by analysis with a Nanodrop ND-1000 to determine protein concentration, 
was run through HPLC, and the recovered fraction showing the greatest amount of activity was 
submitted to the Oklahoma State University Core Facility for analysis by mass spectrometry. The 
protein concentration and biological activity (AU) obtained in each step throughout the process 
are documented below in Table 2.5. 
Mass Spectrometry 
Numerous bacteriocins are produced by streptococci known to be lantibiotics, which contain 
lanthionine and have many post-translational modifications. Because these contain unusual amino 
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acids, they are not as readily discernible by mass spectrometry protein fragmentation for identity 
as are traditional peptides. 
 
 









Figure 2.6. Activity of precipitate derived from 30% ammonium sulfate saturation fractionation 
followed by elution through a C18 column with 50% isopropanol.  
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Culture Supernatant (M17 Medium) 168,000  4226.60 39.75 100.00% 1 
Ammonium Sulfate Precipitation 30% Saturation 51,200 37.53 909.95 30.48% 22.89 
Sep-Pack / C18 Original Am. Sulf. 30% Eluate 3200 15.65 204.52 1.90% 5.15 
Sep-Pack / C18 Water Wash 0 1.70 0 0.00% 0 
Sep-Pack / C18 25% Fraction 3200 5.08 629.51 1.90% 15.84 
Sep-Pack / C18 50% Fraction 6400 2.84 2253.52 3.81% 56.69 
Sep-Pack / C18 75% Fraction 0 0.15 0 0.00% 0 
Sep-Pack / C18 100% Fraction 0 0.03 0 0.00% 0 
      
Ammonium Sulfate Precipitation 40% Saturation 25600 56.27 349.73 15.24% 8.80 
Sep-Pack / C18 Original Am. Sulf. 40% Eluate 3200 16.98 188.46 1.90% 4.74 
Sep-Pack / C18 Water Wash 0 2.88 0 0.00% 0 
Sep-Pack / C18 25% Fraction 12,800 15.66 817.37 7.62% 20.56 
Sep-Pack / C18 50% Fraction 400 1.21 329.67 0.24% 8.29 
Sep-Pack / C18 75% Fraction 0 0.16 0 0.00% 0 
Sep-Pack / C18 100% Fraction 0 0.056 0 0.00% 0 
HPLC Purification (RP-C4, Acetonitrile)–Fract. #12 320 0.015 21,333.33 0.19% 536.69 
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As can be seen from the table above, the best crude purification was achieved by precipitating 
protein at 30% ammonium sulfate saturation, followed by elution from a C18 column with 50% 
isopropanol. Other eluates yielded a significant amount of bacteriocin, but this fraction yielded 
the best sample, as it displayed the highest specific activity (AU/mg protein). Overall, 45.72% of 
the bacteriocin was recovered in the ammonium sulfate fractions and after elution through the 
C18 cartridge, the purest fraction resulted in a 56.69-fold purification with a specific activity of 
2253.52 AU/mg. During the HPLC fractionation, the bacteriocin eluted in the 12th fraction, which 
represented elutions from the 22-24 minute time period during the HPLC run. This fraction was 
dried and resuspended in 100-µL of water and showed a specific activity of 21,333.33 AU/mg 
protein, demonstrating a 536.69-fold level of purification. The HPLC step resulted in a nearly 10-








Figure 2.7. Fractionation using HPLC.  The enlarged peak, showing detection at 280 nm, 
indicates the presence of the bacteriocin. When the fraction was recovered and spotted, inhibitory 


























Because lactic acid bacteria have GRAS status and can be used in foods, bacteriocins from these 
sources have become subjects of interest as antimicrobial measures against L. monocytogenes in 
food. In order to incorporate bacteriocins as antimicrobials in foods, each bacteriocin should be 
tested in each food for which it is intended. The main reason for this is that bacteriocins act 
differently in media than they do in food products, as the constituents within the food can affect 
the activity of the bacteriocins. These antimicrobial peptides are amphiphilic in nature and can 
bind to protein or fat and can degrade over storage periods (Budde et al., 2003; Hartmann et al., 
2011). Bacteriocins within different foods could also react differently based on the amounts of 
various constituents within the foods.  
The ability for L. monocytogenes to become resistant to bacteriocins has been noted (Gravesen et 
al., 2002; Kaur et al., 2011). The use of multiple mode-of-action (MOA) bacteriocin mixtures is a 
promising solution to this issue. Use of bacteriocins possessing different MOAs greatly decreases 
the likelihood of Listeria gaining bacteriocin resistance to the mixture. However, prior to 
implementation in foods, strains whose bacteriocins are to be used should be analyzed for 
virulence factors, as certain cultures can produce these.  
For this study, the selection of spontaneously-resistant L. monocytogenes 39-2 allowed for the 
development of resistant isolates, which were then used to screen samples for the use of a novel 
MOA. This process yielded 6 isolates during the course of our studies. Isolates belonging to a 
genus that could potentially contain virulence factors were analyzed for hemolysin and gelatinase 
production. Four of the strains analyzed produced gelatinase, while only the control organism 
produced hemolysin; none of these were chosen for use in our applications in further studies.  
The Streptococcus spp. 323 isolate produced a bacteriocin with considerable antagonistic activity 
against the most resistant Listeria strain, was grown in M17 medium without Tween and purified 
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SHELF-LIFE STUDIES EVALUATING THE EFFECTIVENSS OF MULTIPLE MODE-
OF-ACTION BACTERIOCIN COCKTAIL IN COMPARISON WITH COMMERCIAL 
NATURAL ANTIMICROBIALS IN HOTDOGS  
 
ABSTRACT 
Consumer preferences for natural, ingredients and the implication of Listeria monocytogenes in 
recent outbreaks originating from RTE products have indicated the need for effective, naturally-
derived antimicrobials to ensure the safety of such products.  Lactic acid bacteria (LAB) produce 
bacteriocins that display antagonistic effects against L. monocytogenes, which may present a 
solution for use in foods targeting the organism. 
Our objectives were to analyze a multiple MOA bacteriocin cocktail and commercial 
antimicrobials through shelf-life studies challenged with L. monocytogenes. 
Previously, a L. monocytogenes strain resistant to three different MOAs was made, which was 
then utilized to screen samples for a bacteriocin possessing an uncommon MOA, leading to the 
isolation of Streptococcus spp. strain 323. Along with this strain, three other LAB operating by 
two different MOA (Lactobacillus curvatus Beef 3, Lactococcus lactis FLS-1, and Pediococcus 




The bacteriocin cocktail was compared to commercial antimicrobials NovaGard® (Dow) and 
Durafresh™ 2016 (Kerry) in shelf life studies to compare the antimicrobial treatments on 
hotdogs. Studies were conducted using high and low inoculums of a four-strain cocktail of 
Listeria monocytogenes (L. monocytogenes 39-2, L. monocytogenes V7-2, L. monocytogenes 383-
2, L. monocytogenes CW2) on hotdogs free of other antimicrobial compounds, which were 
manufactured within the FAPC pilot plant. After inoculation, hotdogs were stored at 5°C and 
sampled periodically by plating on MOX agar for L. monocytogenes and MRSA pH 5.5 for LAB.  
The addition of a bacteriocin cocktail to hot dog surfaces proved sufficient for maintaining 
Listeria levels below 3.0 log for 6 and 8 weeks in high and low inoculum studies, respectively. 
Application of a bacteriocin cocktail within the meat matrix during manufacture kept Listeria 
levels below 3.0 log CFU/mL after 16 weeks. Bacteriocins exhibited significantly better 
inhibition than NovaGard® at both concentrations applied and performed better than Durafresh™ 
2016 at higher concentrations.  
Given the data gathered in this study, multiple MOA bacteriocins for use as a hurdle technology 
could effectively reduce levels of Listeria in RTE products. 
 
INTRODUCTION 
RTE meats are particularly vulnerable to contamination with Listeria monocytogenes, a 
particularly dangerous pathogen responsible for approximately 260 deaths each year (Centers for 
Disease Control and Prevention, 2017). These products are of concern due to their long shelf life 
and favorable environment for Listeria growth. The pathogen is particularly problematic due to 
its ubiquitous nature, its salt tolerance, and its ability to grow at low temperatures. Contamination 
typically occurs post-processing before the product is packaged. While the food industry has 
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addressed this issue by applying lactates and diacetates to products, such chemicals do not align 
with consumer preferences.  
Bacteriocins have been proposed as a natural alternative to these antimicrobials. Because LAB 
are GRAS ingredients, direct addition of the cultures producing the bacteriocins or the addition of 
their fermented products to foods requires no approval (Deegan et al., 2006). Not only do these 
naturally-occurring antimicrobial peptides produced by LAB prevent growth of L. 
monocytogenes, but they also are ideal for use in food products because they are heat stable 
(Perez et al., 2014). In other words, the addition of these compounds to foods would not have 
minimal effects on the flavor of the product itself and could be applied even prior to cooking 
product. By using bacteriocins, an effective natural intervention would be possible for industry, 
greatly decreasing the likelihood of Listeria growth in the product, should it become 
contaminated during manufacture. 
Bacteriocins have already been implemented in several commercial products, including 
Nisaplin® and ALTA 2341™. While these products have antilisterial effects, they each include 
only one type of bacteriocin. This could become a serious issue, as L. monocytogenes can gain 
spontaneous resistance to bacteriocins. Fortunately, bacteriocins work by different MOAs, so 
when Listeria gains resistance to one bacteriocin, it is still susceptible to bacteriocins employing a 
different MOA. This was demonstrated by Macwana and Muriana (2011), who were able to 
identify bacteriocins based on MOA by using bacteriocin-resistant L. monocytogenes strains as a 
screening process. 
By combining bacteriocins with different MOAs, any potential Listeria that may come into 
contact with this blend would have additional obstacles to overcome, thereby adding to the 
protection of the food to which the bacteriocins are applied. Such bacteriocin cocktails were 
previously researched by Vijayakumar and Muriana (2017); however, the effectiveness of such 
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bacteriocin blends when compared to commercial natural antimicrobials has not been evaluated, 
which would be vital information if multiple MOA bacteriocin cocktails were to be implemented 
in industry. 
The objectives of this research were to a) evaluate the effectiveness of a surface-inoculated 
multiple MOA bacteriocin cocktail against a 4-strain mixture of L. monocytogenes when 
compared to NovaGard® and Durafresh™ 2016 in a hotdog shelf-life study and b) evaluate the 
effectiveness of alternative applications of the bacteriocin cocktail against the 4-strain blend of 
Listeria monocytogenes on hotdogs. 
Results of this work could help determine the feasibility of use of multiple MOA bacteriocin 
cocktails in the food industry and determine the best bacteriocin application method to achieve 





MATERIALS AND METHODS 
Preparation of Cultures for Use in Studies 
Master cultures of bacteriocin-producing lactic acid bacteria (LAB) from the Muriana laboratory 
collection, which were used in previous studies, were stored at -80°C in milk-based freezing 
medium containing 11% non-fat dry milk, 1% glucose, and 0.2% yeast extract. Similarly, Listeria 
strains were stored in 11% non-fat dry milk, 1% glucose, and 0.2% yeast extract. Cultures used as 
working stocks were made by inoculating 9 mL of either MRS (LAB cultures) or TSB (L. 
monocytogenes cultures) broths with 100-µL of culture and growing overnight for 16 hours at 
30°C. These were then streaked for isolation, and a single colony was selected and grown for 16 
hours at 30°C before preparing cultures for freezing. Cultures were centrifuged at 8000 rpm with 
a SS-34 rotor in a Sorvall® RC 5C Plus centrifuge for 10 minutes, supernatant was discarded, and 
the remaining pellet was resuspended in milk-based freezing medium as previously described for 
storage at -80°C. From these cultures, bacteria needed for studies were propagated twice 
overnight for 16 hours before use. 
Formation of Multiple Mode of Action Bacteriocin Cocktail 
The multiple mode of action (MOA) bacteriocin cocktail was chosen based on the different MOA 
each bacteriocin displayed, as well as absence of virulence factors in the producing organism and 
amount of bacteriocin activity produced. Cultures from different MOAs were selected based on 
these criteria, resulting in a bacteriocin cocktail consisting of cell free supernatant (CFS) from 
Pediococcus acidilactici Bac 3, Lactobacillus curvatus Beef 3, Lactococcus lactis FLS-1, and 






Table 3.1. Cultures used in this study 
Bacterium Strain Source 
Bacteriocin Cocktail 1 
Pediococcus acidilactici Bac 3 Muriana Culture Collection 
Lactobacillus curvatus Beef 3 Vijayakumar & Muriana, 2017 
Lactococcus lactis FLS-1 Vijayakumar & Muriana, 2017 
Streptococcus lutetiensis 323 This Study 
Bacteriocin Cocktail 2 
Lactobacillus curvatus FS47 Garver and Muriana, 1993 
Enterococcus faecium  FS56-1 Garver and Muriana, 1993 
Pediococcus acidilactici Bac 3 Muriana Culture Collection 
Lactobacillus curvatus Beef 3 Vijayakumar & Muriana, 2017 
Lactococcus lactis FLS-1 Vijayakumar & Muriana, 2017 
Listeria monocytogenes Cocktail 
Listeria monocytogenes 39-2 Muriana Culture Collection 
Listeria monocytogenes V7-2 Muriana Culture Collection 
Listeria monocytogenes  383-2 Muriana Culture Collection 
Listeria monocytogenes CW2 Muriana Culture Collection 
 
Alongside this bacteriocin cocktail (Bac #1), another bacteriocin cocktail (Bac #2) previously 
created within our laboratory, included 3 MOA and used in Vijayakumar and Muriana (2017), 
was chosen to test on hotdogs as well (Table 3.1). Strains of L. monocytogenes were also selected 
to be combined in a 4-strain cocktail as challenge organisms (Table 3.1) for application to the 
surface of hotdogs. 
Production of Hotdogs 
Hotdogs were produced in the meat processing pilot plant of the Robert M. Kerr Food and 
Agricultural Products Center. The performance of bacteriocin cocktails were compared to the 
effectiveness of two different commercial antimicrobials, which included NovaGard® (Dow), 
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applied at 0.25% of the total formulation, and Durafresh™ 2016 (Kerry), applied at 1% of the 
total formulation. Kerry also requested testing Durafresh alongisde a celery powder product, 
Accel™ 2000 (recommended application between 0.15 and 0.85%), which they are now using in 
place of traditional cure. Formulations for all batches can be shown below in Tables 3.2 through 
3.6. Using fat percentage estimates obtained from a FOSS FoodScan™ after grinding beef trim, 
lean pork, and pork belly separately, meat was blended together to formulate an approximately 
17% fat hotdog.  
 
Table 3.2. Formulation for control hotdogs / bacteriocin-soaked casing hotdogs 
Ingredient Formula % Lbs Grams 
Beef Trim 12.71% 4.50 2041.16 
Lean Pork 37.43% 13.25 6010.09 
Pork Belly 20.48% 7.25 3288.54 
Water 26.70% 9.45 4286.44 
Seasoning 2.47% 0.88 396.89 
Cure (6.25% NO2) 0.18% 0.06 28.30 
Sodium Erythrobate 0.03% 0.01 4.54 
Total 100% 35.40 16055.96 
 
Table 3.3. Formulation for hotdogs with bacteriocin addition in meat matrix 
Ingredient Formula % Lbs Grams 
Beef Trim 12.72% 6.43 2916.60 
Lean Pork 37.39% 18.90 8572.89 
Pork Belly 20.50% 10.36 4699.21 
Bacteriocin Mix 26.71% 13.50 6123.49 
Seasoning 2.47% 1.25 566.99 
Cure (6.25% NO2) 0.18% 0.09 40.51 
Sodium Erythrobate 0.03% 0.01 6.49 




Table 3.4. Formulation for NovaGard hotdogs 
Ingredient Formula % Lbs Grams 
Beef Trim 12.68% 4.50 2041.17 
Lean Pork 37.33% 13.25 6010.09 
Pork Belly 20.43% 7.25 3288.54 
Water 26.63% 9.45 4286.49 
Seasoning 2.47% 0.88 396.89 
NovaGard 0.25% 0.09 40.38 
Cure (6.25% NO2) 0.18% 0.06 28.30 
Sodium Erythrobate 0.03% 0.01 4.51 
Total 100% 35.49 16096.37 
 
Table 3.5. Formulation for Durafresh 2016 with chemical sodium nitrite hotdogs 
Ingredient Formula % Lbs Grams 
Beef Trim 12.57% 4.50 2038.87 
Lean Pork 37.06% 13.25 6010.09 
Pork Belly 20.28% 7.25 3288.53 
Water 26.43% 9.45 4286.48 
Seasoning 2.45% 0.88 396.89 
Durafresh 1.00% 0.36 162.74 
Cure (6.25% NO2) 0.18% 0.06 28.30 
Sodium Erythrobate 0.03% 0.01 4.51 





Table 3.6. Formulation for Durafresh 2016 with Accel 2000 hotdogs 
Ingredient Formula % Lbs Grams 
Beef Trim 12.53% 4.50 2038.50 
Lean Pork 36.94% 13.25 6011.82 
Pork Belly 20.21% 7.25 3289.48 
Water 26.35% 9.45 4287.71 
Seasoning 2.45% 0.88 396.89 
Durafresh 1.00% 0.36 162.81 
Sodium Erythrobate 0.03% 0.01 4.51 
Accel 0.50% 0.18 80.97 
Total 100% 35.88 16272.69 
 
Hotdog emulsions were prepared by combining ground lean meat, salt, water, and half of the 
seasonings, and mixing in a Seydelmann bowl chopper for 2 minutes. Then ground fatty meat 
was added, along with the remainder of the water and mixed until a temperature of 12.7°C (55°F) 
was achieved. No lactates or diacetates were applied to the mixture. The emulsion was then 
stuffed into 24/USA Viscofan cellulose casings, with the exception of a bacteriocin-soaked 
casings batch, which had 24/USA Viscofan cellulose casings soaked in bacteriocin cocktail #1 for 
30 minutes prior to the stuffing step. Liquid smoke was then applied to the casings, ensuring the 
coating of every surface. Frankfurters were then placed in an Alkar RapidPak electric batch oven 
and the protocol listed below in Table 3.7 was applied. After hotdogs reached an internal 
temperature of 71.1°C (160°F), they were subjected to a cold shower, then cooled to a core 












130 93 20 
160 128 20 
175 145 20 
190 165 5 
 
Preparation for Shelf Life Studies 
Bacteriocins were prepared by propagating each culture from frozen working culture twice for 16 
hours at 30°C prior to centrifuging. After cells were eliminated, supernatants from each culture 
were mixed to obtain a crude bacteriocin cocktail. The cocktail was then pasteurized at 80°C for 
15 minutes to remove any remaining cells, then stored at 4°C prior to use. A two-fold dilution 
titer assay, as previously described, was used to ensure activity of the mixed bacteriocin cocktail. 
Four strains of L. monocytogenes (Table 3.1) were propagated twice for 16 hours at 30°C. Prior to 
application on hotdogs, the separate strains were mixed together in equal amounts and diluted to 
the desired inoculum concentration in order to achieve a 3 or 4 log CFU/mL when applied to the 
hotdogs, depending on the study being conducted. 
Frozen hotdogs were thawed at 4°C overnight prior to use. A vat pasteurizer with temperature 
controls was used to pasteurize hotdogs at 80°C for 5 minutes. This was done remove any 
incidental background lactic acid bacteria that could potentially grow during refrigerated shelf-
life storage and contribute to Listeria inhibition. Frankfurters were then allowed to cool on ice for 
one hour prior to inoculation.  
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Pasteurized, cooled hotdogs were aseptically transferred to 8 x 10-in. high barrier vacuum 
packages (Prime Source, Kansas City, MO; 3 mil high barrier nylon vacuum pouch, Item No. 
75001942) with two frankfurters allotted per package. Each package had 300 µL of bacteriocin 
cocktail applied to the surface of the hotdogs, which were then hand-massaged to distribute 
bacteriocin. In the case of the control batch and commercial antimicrobial batches, frankfurters 
instead had 300-µL of DI water applied to the surface to keep moisture levels between all batches 
the same. 
The L. monocytogenes 4-strain cocktail was then applied to all hotdog packages, in a 100-µL 
volume. The hotdogs were again hand-massaged to distribute the inoculum. Frankfurters were 
then vacuum-packaged and kept at 5°C until required for sampling.  
Sampling Procedure 
Test packages of frankfurters were sampled in triplicate at 0, 1, and 3 days, followed by weekly 
sampling until the 4-week period, then biweekly sampling periods for up to 20 weeks. For each 
sampling period, 3 random packages were withdrawn from the incubator and sanitized with 
alcohol before slicing a hole in one corner. Through this opening, 3-mL of 0.1% buffered peptone 
water (BPW) was added to the frankfurters. The hotdogs were then hand-massaged to promote 
dispersal of the Listeria into the liquid. The liquid was then extracted, treating this as the 100 
dilution, and then further 10-fold dilutions were made with 0.1% BPW. Dilutions were plated 
onto Modified Oxford Medium agar (MOX) to enumerate L. monocytogenes, as well as pH 5.5 





RESULTS AND DISCUSSION 
Formation of Multiple Mode of Action Mixed Bacteriocin Cocktail 
Classification of bacteriocins by mode of action (MOA) and determination of the amount of 
activity each bacteriocin displayed against L. monocytogenes strains allowed for the formation of  
multiple MOA bacteriocin cocktail #1 for use in this study. Strains chosen for the multiple MOA 
bacteriocin cocktail represented 3 MOA and included Streptococcus spp. 323, Lactococcus lactis 
FLS-1, Lactobacillus curvatus Beef 3, and Pediococcus acidilactici Bac3. Cell-free supernatants 
(CFS) of these strains were combined and evaluated against each Listeria monocytogenes strain 
chosen for use in hotdogs using a serial two-fold dilution titer assay (Figure 3.1). From the titer 
assay, the inhibitory activity units (AU) against each Listeria strain were calculated (Table 3.9).  
Table 3.8. Strains of each bacteriocin cocktail used in this study 
Bacteriocin-Producing Strain Used Mode of Action Used 
 #1 #2 #3 #4 
Bacteriocin Cocktail #1 (This Study) 
Pediococcus acidilactici Bac 3     
Lactobacillus curvatus Beef 3     
Lactococcus lactis FLS-1     
Streptococcus spp. 323     
Bacteriocin Cocktail #2 (Vijayakumar & Muriana, 2017) 
Pediococcus acidilactici Bac 3     
Lactobacillus curvatus Beef 3     
Lactobacillus curvatus FS47     
Lactococcus lactis FLS-1     
Enterococcus faecium FS56-1     
 
Table 3.9. Activity of bacteriocin cocktail #1 against L. monocytogenes strains used in this study 
Strain Bacteriocin Cocktail #1 AU/mL 
L. monocytogenes V7-2 25,600 
L. monocytogenes 383-2 25,600 
L. monocytogenes 39-2 25,600 


















Figure 3.1. Two-fold dilution bacteriocin cocktail titer assay against strains of Listeria 
monocytogenes used in this study. Panel A, bacteriocin cocktail (Pediococcus acidilactici Bac3, 
Lactobacillus curvatus Beef 3, Lactococcus lactis FLS-1, and Streptococcus spp. 323) activity 
against L. monocytogenes 39-2; Panel B, bacteriocin cocktail activity against L. monocytogenes 
383-2; Panel C, bacteriocin cocktail activity against L. monocytogenes V7-2; Panel D, activity of 
bacteriocin cocktail against L. monocytogenes CW2. This is the visual representation of bacteriocin 








Production of Hotdogs 
Hotdogs were chosen for use in this study due to their high risk of contamination with L. 
monocytogenes (Center for Food Safety & Applied Nutrition et al., 2003). The susceptibility of  
product contamination with Listeria combined with their long shelf life made them an ideal 
candidate to test the application of bacteriocins. Post-processing contamination could be 
catastrophic for such foods due to the ability of the pathogen to grow at refrigerated temperatures. 
In order to evaluate the effectiveness of the multiple MOA bacteriocin cocktail, it also was 
essential to exclude lactates and diacetates from the hotdog formulation. While lactates and 
diacetates are commonly used in industry as preventive measures against L. monocytogenes, the 
incorporation of other antimicrobials would not demonstrate the true antimicrobial potential of 
the bacteriocin or commercial antimicrobial being tested.  
Preparation for Shelf Life Studies 
After culturing bacteriocin-producing cultures, supernatants were prepared and combined. The 
bacteriocin cocktails (Bac#1 and Bac#2) were then evaluated against the Listeria strains to be 
used in the studies for each trial using a two-fold dilution titer assay. Inhibitory AU were noted 







Figure 3.2. Activity of bacteriocin cocktails applied to each hotdog shelf life challenge study. Panel 
A, Bacteriocin Cocktail #1 (this study) activity against Listeria monocytogenes cocktail for high 
inoculation hotdog challenge study; Panel B, Bacteriocin Cocktail #1 (this study) activity against 
L. monocytogenes cocktail for low inoculation hotdog challenge study; Panel C, Bacteriocin 
Cocktail #1 (this study) activity against L. monocytogenes cocktail for alternative bacteriocin 
application and bacteriocin within meat matrix hotdog challenge study; Panel D, Bacteriocin 
Cocktail #2 (Vijayakumar & Muriana, 2017) activity against L. monocytogenes cocktail for high 
inoculation hotdog challenge study; Panel E, Bacteriocin Cocktail #2 (Vijayakumar & Muriana, 
2017) activity against L. monocytogenes cocktail for low inoculation hotdog challenge study; Panel 
F, Bacteriocin Cocktail #2 (Vijayakumar & Muriana, 2017) activity against L. monocytogenes 





Table 3.10. Activity of bacteriocin cocktails applied in each shelf life study 
Study Bacteriocin Cocktail 
#1 (This Study) 
Bacteriocin Cocktail 
#2 (Vijayakumar & 
Muriana, 2017)  
Study 1: Surface Application with High 
Listeria monocytogenes inoculation 
25,600 25,600 
Study 2: Surface Application with Low 
Listeria monocytogenes inoculation 
25,600 25,600 
Study 3: Bacteriocin-Soaked Casings and 




Sampling Procedure and Analysis 
Previously, Vijayakumar and Muriana (2017) found the use of acidified MRS agar allowed the 
growth of lactic acid bacteria but inhibited the growth of L. monocytogenes, while MOX allowed 
the growth of Listeria but inhibited the growth of lactic acid bacteria. Prior to the hotdog trials in 
this study, strains were tested on these agars to confirm growth only occurred of desired 
organisms on each medium. After successfully confirming the validity of the test, acidified MRS 
agar was used to test for the presence of contaminating LAB in the studies conducted, while 
MOX was used to enumerate the inoculated L. monocytogenes. At each sampling period, 3 
packages were sampled and plated in duplicate. The graphs depicting the data collected are 
shown below in Figures 3.3, 3.4, and 3.5. Statistical analysis was performed using SigmaPlot 13 
One-Way Repeated Measures ANOVA, with significant differences among data being 
determined at p < 0.05. 
Shelf Life Study 
Three hotdog shelf-life challenge studies in were conducted using the 3 MOA bacteriocin cocktail 
formulated for this study (Bac #1), as well as the multiple MOA bacteriocin cocktail (Bac #2) 
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used in Vijayakumar and Muriana (2017). In addition, the effects of two commercial antilisterial 
products were evaluated, as well as a comparison between chemical sodium nitrite and a natural 
celery alternative (Accel 2000) with respect to their influence on L. monocytogenes. Figures 
below show results, along with discussion of the results of each study. 
Listeria monocytogenes has been implicated in outbreaks with ready-to-eat (RTE) foods (Gombas 
et al., 2003), and many studies have found bacteriocins to be effective in meat models against L. 
monocytogenes (Chen et al., 2004; Du et al., 2017; Murray & Richard, 1997; Nieto-Lozano et al., 
2010; Vijayakumar & Muriana, 2017). Therefore, evaluation of multiple MOA bacteriocin 







Figure 3.3. Hotdog challenge study with high inoculation of Listeria monocytogenes 4-strain 
cocktails. A 4-strain cocktail of L. monocytogenes was inoculated on hotdogs at 4 log CFU/mL 
by itself (control), with bacteriocin cocktail #1 (Lactobacillus curvatus Beef 3, Pediococcus 
acidilactici Bac3, Lactococcus lactis FLS-1, Streptococcus spp. 323), bacteriocin cocktail #2 
(Enterococcus faecalis FS56-1, Lb. curvatus Beef 3, P. acidilactici Bac3, Lc. lactis FLS-1, and 
Lb. curvatus FS47), NovaGard, Durafresh 2016 with chemical sodium nitrite, or Durafresh 2016 
with Accel 2000 (natural nitrite). All sample treatments were performed in triplicate replication; 
data points represent the mean and error bars represent the standard deviation from the mean. 
Treatment with different lowercase letters are significantly different (repeated measures ANOVA, 





Study 1: High Inoculation with 4-Strain Listeria monocytogenes Cocktail 
The first shelf-life challenge study examined the effect of a high inoculum (4 log CFU/mL) of a 
4-strain cocktail of L. monocytogenes on hotdogs with different antimicrobial treatments and a 
control, resulting in 6 different batches. These included NovaGard (Danisco, added at 0.25%), 
Durafresh 2016 (Kerry, added at 1.0%) using sodium nitrite (156 ppm) as the nitrite source, 
Durafresh 2016 (Kerry, added at 1.0%) using Accel 2000 as the nitrite source (Kerry, added at 
100ppm), and two different bacteriocin cocktails, bacteriocin cocktail #1 (CFS from 
Lactobacillus curvatus Beef 3,  Pediococcus acidilactici Bac 3,  Lactococcus lactis FLS-1, and 
Streptococcus spp. 323) and bacteriocin cocktail #2 (CFS from Lactobacillus curvatus FS47, 
Enterococcus faecium FS56-1, Lactobacillus curvatus Beef 3,  Pediococcus acidilactici Bac 3, 
and  Lactococcus lactis FLS-1). 
Statistical analysis indicated a significant difference (p < 0.05) between the control and all other 
treatments over the course of the study. Bacteriocin treatments did not significantly differ from 
each other, and similarly, the Durafresh 2016 batches comparing the use of chemical sodium 
nitrite and Accel 2000 (natural nitrite) had no significant difference from each other. A significant 
difference (p < 0.001) was observed between the bacteriocin treatments and both Durafresh 2016 
batches. NovaGard had a significant difference when compared to both Durafresh 2016 batches 
and both bacteriocin batches (p < 0.001). Growth of LAB did not occur at any point during the 
study, indicating the effectiveness of the pasteurization step (Figure 3.3).  
A loss of bacteriocin activity during storage or when applied to a food has been well-documented 
and is not unusual (Aasen et al., 2003; Kouakou et al., 2009; Woraprayote et al., 2016). 
Bacteriocins have the ability to bind to components within a food, such as proteins and fat. Other 
factors can also contribute to loss of bacteriocin activity, including proteolytic activity and 
oxidation (Aasen et al., 2003; Kouakou et al., 2009). To illustrate this, a study conducted by 
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Aasen et al. (2003), determined bacteriocin activity of sakacin P before and after incubation for 4 
weeks in salmon and chicken. Results of the study found an approximate loss of 80% of the 
sakacin P activity and an average loss of 2-µg/g in salmon and 3-4 µg/g in chicken models. The 
study also observed a higher recovery rate of bacteriocin activity at more acidic conditions tested, 
though degradation of bacteriocin activity still occurred with these conditions. Given this 
information, it is a logical conclusion that the increase in L. monocytogenes observed in this study 







Figure 3.4. Hotdog challenge study with low inoculation of Listeria monocytogenes 4-strain 
cocktail. A 4-strain cocktail of L. monocytogenes was inoculated on hotdogs at 3 log CFU/mL by 
itself (control), with bacteriocin cocktail 1 (Lactobacillus curvatus Beef 3, Pediococcus 
acidilactici Bac3, Lactococcus lactis FLS-1, Streptococcus spp. 323), bacteriocin cocktail 2 
(Enterococcus faecalis FS56-1, Lb. curvatus Beef 3, P. acidilactici Bac3, Lc. lactis FLS-1, and 
Lb. curvatus FS47), NovaGard, Durafresh 2016 with chemical sodium nitrite, or Durafresh 2016 
with Accel 2000 (natural nitrite). All sample treatments were performed in triplicate replication; 
data points represent the mean and error bars represent the standard deviation from the mean. 
Treatment with different lowercase letters are significantly different (repeated measures ANOVA, 







Study 2: Low Inoculation with 4-Strain Listeria monocytogenes Cocktail 
Study 2 observed the effect of a low inoculum (3 log CFU/mL) of the 4-strain L. monocytogenes 
cocktail against the same antimicrobials used Study 1. For this, statistical analysis using One-
Way Repeated Measures ANOVA indicated both bacteriocin batches showed a significant 
reduction from the control batch throughout the study (p < 0.001). Similarly, both Durafresh 2016 
batches showed a significant reduction from the control throughout the study. Durafresh and 
bacteriocin treatments performed significantly better than NovaGard p < 0.001), showing lower 
levels of L. monocytogenes. The hotdogs treated with NovaGard did not show a statistically 
significant difference (p = 0.866) relative to the control but did statistically differ from the 
remaining hotdog batches (p < 0.001). Batches with bacteriocin applications did not differ 
significantly from each other (p = 0.958), while Durafresh 2016 batches comparing use of sodium 
nitrite to Accel 2000 showed no statistical difference from each other (p =0 .924). Growth of 
LAB was not observed during the study on acidified MRS agar, which proved the effectiveness of 
the pasteurization step to remove background bacteria (Figure 3.4). 
Accounting for Differences Between Studies 1 and 2 
Differing results between hotdog batches in study 1 and study 2 were sources of concern. After 
proximate analysis of batches were performed by the Food and Agricultural Products Center 
Chemical Analysis laboratory (Table 3.11), results indicated fat percentages differed from each 
other by about 5 percent and protein differed by about 2 percent. This issue could have been 
avoided by formulating hotdogs for all studies at the same time with the same meat sources. This 
was not as much of a concern in study 3, as the proximate analysis for these hotdogs differed 
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from those in study 1 in the proximate analysis by only about 1% for both fat and protein 
amounts. 
 
Table 3.11. Proximate analysis of hotdogs from each study 
 
Similarities Between Use of Sodium Nitrite and Accel 2000 
The similarities between the Durafresh 2016 batch with sodium nitrite and the Durafresh 2016 
with Accel 2000 were expected. Sodium nitrite and the celery powder from which the Accel 2000 
containing nitrite is made are intended to inhibit the germination of Clostridium spp., rather than 
L. monocytogenes. When compared to the chemical sodium nitrite, the Accel 2000 showed no 
significant difference in the amount of L. monocytogenes in study 1 or study 2 (p=0.926, p=0.924 
respectively). Kouakou et al. (2009) found a slight inhibition of L. monocytogenes by nitrites 
when used in a pork meat model totaling between a 1 and 2 log difference from the control batch 
after a 6-week incubation period. However, the research conducted in this study did not evaluate 
any hotdogs made without nitrites in order to evaluate the overall effect of nitrites on the level of 
L. monocytogenes. Therefore for the purposes of this study, no conclusions regarding inhibition 
of L. monocytogenes can be made.  
Concentration of Bacteriocin 
Study % Moisture % Ash % Fat % Protein % Carbohydrates 
Study 1 Hotdogs 63.61 2.84 17.81 14.22 1.52 
Study 2 Hotdogs 67.33 2.78 12.11 16.12 1.66 
Study 3 Hotdogs 62.20 2.25 18.30 15.24 2.01 
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After seeing the late rise of L. monocytogenes in bacteriocin surface treatments, it was 
hypothesized that a higher concentration or a lower level of L. monocytogenes inoculum would 
result in better inhibition of the pathogen. The high concentration of bacteriocin also would be 
more comparable to the amount of NovaGard or Durafresh 2016 used in previous challenge 
studies, as these are freeze-dried products, while the bacteriocin present in bacteriocin cocktails 
are much more dilute. This led to the formulation of the hotdogs with bacteriocin replacing water 
within the hotdog meat emulsion. Hartmann et al. (2011), and Schillinger et al. (1996) discussed 
the issue of decreased bacteriocin activity in foods when compared to applications in media. To 
alleviate this issue, an increase in bacteriocin concentrations within foods would be a simple 
solution. Based on the results seen, activity of bacteriocin depends on the concentration of the 
antimicrobial within the matrix it is applied. This can be observed by the difference in bacteriocin 
batches in studies 2 and 3 (Figures 3.4 and 3.5, respectively), where the differences in the amount 
of bacteriocin applied to hotdogs resulted in large differences in the amount of L. monocytogenes 
inhibited. For instance, comparing Week 12 of studies 2 and 3, an approximately 3 log CFU/mL 
difference can be observed between the bacteriocin cocktail #2 surface application from study 2 
and bacteriocin cocktail #2 added within the meat matrix in study 3 (Figures 3.4 and 3.5). While 
the high concentration of bacteriocin inhibits the growth of L. monocytogenes quite well, the cost 
of incorporating such a high amount may not be feasible for use in industry. Since contamination 
largely occurs post-processing, surface applications, such as those used in studies 1 and 2 of this 
paper have been a subject of focus, but by soaking casings in bacteriocin, the antimicrobial 
peptides would be in contact with the surface of the product prior to the peeling step, where most 
contamination occurs. Similarly, use of freeze-dried bacteriocin incorporated with packaging has 
also been suggested as a potential solution to prevent surface contamination (Quintavalla & 





Figure 3.5. Hotdog challenge study with bacteriocin-soaked casings and meat matrix bacteriocin 
additions at low inoculation levels of Listeria monocytogenes 4-strain cocktail. A 4-strain cocktail 
of L. monocytogenes was inoculated on hotdogs at 3 log CFU/mL by itself (control), with 
bacteriocin cocktail #1 (Lactobacillus curvatus Beef 3, Pediococcus acidilactici Bac3, 
Lactococcus lactis FLS-1, Streptococcus spp. 323) within the meat matrix, bacteriocin cocktail #1 
within the meat matrix with an additional surface application of the bacteriocin, bacteriocin 
cocktail #2 (Enterococcus faecalis FS56-1, Lb. curvatus Beef 3, P. acidilactici Bac3, Lc. lactis 
FLS-1, and Lb. curvatus FS47) within the meat matrix, bacteriocin cocktail #2 within the meat 
matrix with an additional bacteriocin surface application, and casings soaked in bacteriocin 
cocktail #1. All sample treatments were performed in triplicate replication; data points represent 
the mean and error bars represent the standard deviation from the mean. Treatment with different 




Study 3: Bacteriocin-Soaked Casings and Bacteriocins Applied within the Meat Matrix 
This study analyzed the effect of a low inoculum (3 log CFU/mL) of the 4-strain L. 
monocytogenes cocktail against hotdogs whose casings had soaked for 30 minutes in bacteriocin 
cocktail #1, as well as batches of hotdogs where the water component had been replaced with 
bacteriocin cocktail #1 or bacteriocin cocktail #2. The frankfurters testing the effect of the 
addition of bacteriocin to the meat matrix were split into two treatments; hotdogs with an 
additional 300 µL surface treatment of the respective bacteriocin cocktail, and hotdogs without 
the additional surface treatment. 
Repeated Measures One-Way ANOVA indicated a significant difference between the control and 
all treatments where bacteriocin was added within the meat matrix (Figure 3.5). Batches that had 
bacteriocin applied within the meat matrix all had p-values less than 0.001 when compared to the 
control, indicating a significant difference in treatment. At Week 16 these batches all showed at 
least  6 log CFU/mL less L. monocytogenes from the control. All batches that had bacteriocin 
added within the meat matrix, regardless of the application of an additional surface treatment, had 
no significant difference from each other (p < 0.001).  The batch with the bacteriocin-soaked 
casings showed no significant difference from the control batch, which gave a p-value of 0.984. 
Background bacteria were absent, as no LAB counts were observed on acidified MRS agar 
(Figure 3.5).  
Use of non-neutralized bacteriocins within the meat matrix can cause the pH level to interfere 
with the meat matrix functionality and lead to product failure. This was observed during the 
addition of bacteriocin in place of water within the meat matrix for study 3. It is worth noting that 
pH levels between the batches with the bacteriocin cocktails were only separated by 0.13, but 
only the meat within the batch with the lowest pH level did not remain intact and fell apart after 
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the cooking process (Table 3.12). After observing these results, this batch was discarded. Upon 
increasing the pH of the bacteriocin supernatant to 6.0 prior to incorporation in the meat, no meat 
binding issues were observed with the final product and effective inhibition of the L. 
monocytogenes in the shelf-life study was still observed.  
Table 3.12. Effect of non-neutralized cell-free supernatant containing bacteriocin on hotdog 
batter pH 
Batch pH Product Failure (Yes/No) 
Control 6.03 No 
Bacteriocin Mixture 1 (This Study) 5.53 Yes 
Bacteriocin Mixture 2  5.66 No 
 
The pH within a given product is important regarding the activity of a bacteriocin. Aasen et al. 
(2003) observed more bacteriocin activity recovery at lower pH levels, while Murray and Richard 
(1997) observed a better bactericidal effect at slightly acidic pH levels and higher growth rates of 
remaining live L. monocytogenes. Rodríguez et al. (2002) reported highest stability of pediocin 
PA-1 at pH levels between 4 and 6, but activity was lost during storage at pH levels above 7. 






The shelf-life trials conducted within this study show that a mixture of bacteriocin fermentates 
with different modes of action (MOA) could be applied as an effective antimicrobial ingredient 
for the inhibition of L. monocytogenes given a high enough concentration of the bacteriocin is 
present. After analysis with One-Way Repeated Measures ANOVA (p < 0.05), initial studies 
showed the surface application of 300 µL of a 3 MOA bacteriocin cocktail to hotdogs inhibited L. 
monocytogenes growth significantly when compared to control hotdogs (p < 0.001) at both high 
and low inoculum applications (Figure 3.3 and 3.4). Similarly, hotdogs formulated with the 
addition of Durafresh 2016 (Kerry) showed significant inhibition of L. monocytogenes (p < 
0.001) in comparison with control hotdogs in the same studies, while NovaGard (Danisco) may 
have only had a statistically significant decrease from the control (p=0.018) at a 4 log CFU/mL 
inoculum level of Listeria monocytogenes (Figure 3.3) but the difference had little practical 
significance. 
Treatments in studies 1 and 2 comparing the effect of sodium nitrite to Accel 2000 (Kerry), a 
celery powder used as a natural alternative to sodium nitrite, showed no significant additional 
inhibition from use of Accel 2000 powder on the Listeria monocytogenes 4-strain cocktail. 
Replacement of water with mixed MOA bacteriocin cocktails within the meat matrix during 
formulation showed a large reduction (at least 6 log CFU/mL for all treatments) in comparison to 
control hotdogs, with all batches showing a significant difference from the control. Batches that 
had an additional 300 µL bacteriocin surface treatment showed the lowest levels of L. 
monocytogenes throughout the shelf life study. Bacteriocin-soaked hotdog casings inhibited 
Listeria growth for a short time but did not display a significant difference when compared to the 
control for the duration of the study. 
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Bacteriocin treatments were shown to be effective against a 4-strain Listeria monocytogenes 
cocktail and inhibited growth throughout the shelf life of the product. Given these results, use of 
bacteriocins could be applied in industry as a cheap, natural antimicrobial intervention to improve 
food safety.  In future research, the application of freeze-dried bacteriocin preparations to hotdog 
casings should be examined. Freeze-dried bacteriocins could be easily applied as a powder, and a 
high concentration of soluble bacteriocin would be applied to each hotdog in this way. Such 
measures would address the issue of surface contamination with L. monocytogenes post-
processing. In addition to this, evaluations of the amount of bacteriocin recovery after application 
to products would improve upon knowledge of how the bacteriocins react during shelf life when 
in contact with its intended food constituent, which would also improve upon research performed 
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